<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Front Nutr</journal-id><journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id><journal-title-group><journal-title>Frontiers in Nutrition</journal-title></journal-title-group><issn pub-type="epub">2296-861X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12100629</article-id><article-id pub-id-type="doi">10.3389/fnut.2025.1582861</article-id><article-categories><subj-group subj-group-type="heading"><subject>Nutrition</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Xiao-cui</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2985652/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Li</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/3053119/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xin-han</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/3053072/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Ningxia Regional Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Regional High Incidence Disease, Ningxia Medical University</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Key Laboratory of Ningxia Ethnomedicine Modernization, Ministry of Education, Ningxia Medical University</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Nephrology, Affiliated Hospital of Traditional Chinese Medicine, Ningxia Medical University</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><author-notes><fn id="fn0003" fn-type="edited-by"><p>Edited by: Arpita Mukhopadhyay, St. John&#x02019;s Research Institute, India</p></fn><fn id="fn0004" fn-type="edited-by"><p>Reviewed by: Stefan Kabisch, Charit&#x000e9;, University Medicine Berlin, Germany</p><p>Xiangcheng Fan, Zhejiang University, China</p><p>Vlad P&#x00103;dureanu, University of Medicine and Pharmacy of Craiova, Romania</p></fn><corresp id="c001">*Correspondence: Xiao-cui Wang, <email>wangxc1215@163.com</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1582861</elocation-id><history><date date-type="received"><day>25</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Wang, Song and Wang.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Wang, Song and Wang</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Background</title><p>Non-alcoholic fatty liver disease (NAFLD) has become a public health issue worldwide. Dietary polyphenols are naturally occurring plant active ingredients and are widely employed in the treatment of NAFLD. However, the therapeutic effect is still controversial. In this study, a network meta-analysis (NMA) was performed to appraise the effects of various polyphenols on metabolic indices of NAFLD.</p></sec><sec id="sec2"><title>Methods</title><p>PubMed, Embase, the Cochrane Library, and Web of Science were retrieved for English studies on dietary polyphenols in the treatment of NAFLD. Outcome measures were extracted from the included studies and compared using a Bayesian NMA model, encompassing body mass index (BMI), alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and necrosis factor alpha (TNF-&#x003b1;).</p></sec><sec id="sec3"><title>Results</title><p>In total, 54 randomized controlled trials (RCTs) were included in this study, including 3,132 participants. It involved 13 single (or combined) dietary polyphenols. Naringenin could reduce serum TC (surface under the cumulative ranking curve: 94.59%) and TG (99.00%) in NAFLD patients. Catechin could decrease BMI (77.74%) and serum ALT (94.21%), AST (93.56%), TC (92.26%), and increase HDL-C (93.72%). Dihydromyricetin (DHM) was effective in reducing serum LDL-C (73.22%), and quercetin decreased serum TNF-&#x003b1; (99.47%).</p></sec><sec id="sec4"><title>Conclusion</title><p>Catechin may be the most appropriate dietary polyphenol supplement for NAFLD. Future studies should incorporate more RCTs to further validate the efficacy of dietary polyphenols (like DHM and quercetin), which are limited in sample sizes, in treating NAFLD. On the other hand, it is essential to investigate improvements in the bioavailability of these dietary polyphenols and to clarify their safety profiles.</p></sec></abstract><kwd-group><kwd>non-alcoholic fatty liver disease</kwd><kwd>dietary polyphenol</kwd><kwd>network meta-analysis</kwd><kwd>randomized controlled trials</kwd><kwd>metabolic indices</kwd><kwd>catechin</kwd></kwd-group><funding-group><award-group><funding-source id="cn1">University-Level Research Project of Ningxia Medical University</funding-source><award-id award-type="contract" rid="cn1">XZ2022007</award-id></award-group><award-group><funding-source id="cn2">Special Talent Startup Project of Ningxia Medical University</funding-source><award-id award-type="contract" rid="cn2">XT2022016</award-id></award-group></funding-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the University-Level Research Project of Ningxia Medical University (No. XZ2022007) and the Special Talent Startup Project of Ningxia Medical University (No. XT2022016).</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="8"/><equation-count count="0"/><ref-count count="124"/><page-count count="19"/><word-count count="14555"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Nutrition and Metabolism</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><label>1</label><title>Introduction</title><p>Non-alcoholic fatty liver disease (NAFLD) is the condition of excessive liver fat accumulation, excluding secondary causes and excessive alcohol intake, including two pathologies with various prognoses: non-alcoholic fatty liver and non-alcoholic steatohepatitis (NASH) (<xref rid="ref1" ref-type="bibr">1</xref>). NAFLD is generally believed to be associated with an unhealthy lifestyle, including a high-fat, high-sugar diet and sedentary behavior (<xref rid="ref1" ref-type="bibr">1</xref>). Its pathogenesis is based on the &#x0201c;multiple hit&#x0201d; hypothesis, i.e., it is the result of multiple injuries (such as oxidative stress, lipotoxicity, and inflammatory state) (<xref rid="ref2" ref-type="bibr">2</xref>). NAFLD is the most widespread cause of chronic liver disease across the globe. Between 1990 and 2019, the global prevalence of NAFLD was 30.1%, with 16.02% for NASH (<xref rid="ref3" ref-type="bibr">3</xref>). Over the last 30&#x0202f;years, NAFLD prevalence has grown by 50.4% (<xref rid="ref3" ref-type="bibr">3</xref>). During the 1999&#x02013;2019 survey period in Asia, Mainland China had the highest NAFLD incidence rate, at 63 cases per 1,000 person-years (<xref rid="ref4" ref-type="bibr">4</xref>). NAFLD patients are 1.9 times more likely to develop cancer than the general population (<xref rid="ref5" ref-type="bibr">5</xref>). Extrahepatic cancers like uterine and breast cancer have an incidence rate more than eight times higher than that of hepatocellular carcinoma (HCC) (<xref rid="ref6" ref-type="bibr">6</xref>). In the U.S., NASH is the foremost cause of end-stage liver disease and the second most frequent indication for liver transplantation (<xref rid="ref7" ref-type="bibr">7</xref>). Since the onset of NAFLD is closely linked to cardiometabolic risk factors, such as type 2 diabetes mellitus (T2DM) and obesity, it has gained widespread attention (<xref rid="ref8" ref-type="bibr">8</xref>). NAFLD is now a global public health issue and burden, and this burden is escalating quickly (<xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref9" ref-type="bibr">9</xref>).</p><p>An encouraging development is that in the first half of 2024, the U.S. Food and Drug Administration (FDA) granted approval for resmetirom (Rezdiffra<sup>&#x02122;</sup>) as a treatment for adults with non-cirrhotic NASH and liver fibrosis (<xref rid="ref10" ref-type="bibr">10</xref>), offering new hope for NAFLD treatment. The FDA states that this medication should be used together with diet and exercise, meaning that lifestyle changes remain the key approach in treating NAFLD. Combining the Mediterranean diet (MD), caloric restriction, and moderate- to high-intensity aerobic exercise/resistance training has proven effective in improving metabolic measures of NAFLD (<xref rid="ref11" ref-type="bibr">11</xref>). However, the absence of long-term studies on their impact on the natural progression of NAFLD has prompted the exploration of alternative treatment approaches. Natural products are chemical substances with pharmacological or biological properties naturally produced by living organisms like plants, insects, animals, aquatic organisms and microorganisms (<xref rid="ref12" ref-type="bibr">12</xref>), which are currently a hot research area for the treatment of diseases. Polyphenols are a class of plant-derived compounds, polyphenolic substances or isolated polyphenol monomers extracted from dietary substances or traditional medicines, which belong to the natural product paradigm. Dietary polyphenols, a class of plant-derived compounds found in fruits, tea, and vegetables, exhibit anti-inflammatory and antioxidant properties that can aid in improving the metabolic disturbances in NAFLD (<xref rid="ref13" ref-type="bibr">13</xref>). A meta-analysis has examined the therapeutic effects of eight common dietary polyphenols, including curcumin, on NAFLD (<xref rid="ref14" ref-type="bibr">14</xref>), providing guidance for the clinical selection of dietary polyphenols in NAFLD treatment. However, due to the wide variety of dietary polyphenols, most randomized controlled trials (RCTs) have primarily focused on comparing the efficacy differences between various polyphenols and placebos, without direct comparisons among polyphenols. This gap in evidence can be bridged through network meta-analysis (NMA).</p><p>The NMA is able to simultaneously compare multiple interventions not directly compared in RCTs and rank the effectiveness of the interventions (<xref rid="ref15" ref-type="bibr">15</xref>). Hence, this study intends to compare the efficacy of various single (or combined) dietary polyphenol supplements in the treatment of NAFLD, like curcumin, resveratrol, anthocyanin, silymarin, catechin, chlorogenic acid (CA), ellagic acid (EA), genistin/genistein, naringenin, dihydromyricetin (DHM), hesperidin, quercetin, and gallic acid (GA) and CA, providing evidence-based guidance for both clinicians and patients in selecting appropriate dietary polyphenol therapies for NAFLD.</p></sec><sec sec-type="methods" id="sec6"><label>2</label><title>Methods</title><sec id="sec7"><label>2.1</label><title>Registration</title><p>This study was in line with the preferred reporting items for systematic reviews and meta-analyses extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions (<xref rid="ref16" ref-type="bibr">16</xref>) and was registered in the international prospective register of systematic reviews<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> with the registration number CRD42024591985.</p></sec><sec id="sec8"><label>2.2</label><title>Literature search strategy</title><p>Studies were retrieved from four electronic databases (PubMed, Embase, the Cochrane Library, and Web of Science) up to May 14, 2024. The keywords for the search were &#x0201c;polyphenol,&#x0201d; &#x0201c;phenolic acid,&#x0201d; &#x0201c;silymarin,&#x0201d; &#x0201c;anthocyanidin,&#x0201d; &#x0201c;hesperidin,&#x0201d; &#x0201c;resveratrol,&#x0201d; &#x0201c;nonalcoholic fatty liver,&#x0201d; &#x0201c;non-alcoholic fatty liver disease,&#x0201d; and &#x0201c;NAFLD.&#x0201d; The search formula employed was [(polyphenol) OR (phenolic acid) OR (silymarin) OR (anthocyanidin) OR (hesperidin) OR (resveratrol)] AND [(nonalcoholic fatty liver) OR (non-alcoholic fatty liver disease) OR (NAFLD)]. The detailed search strategy is available in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 1</xref>.</p></sec><sec id="sec9"><label>2.3</label><title>Inclusion criteria</title><p>Population (P): (i) Sex was not limited; (ii) age &#x02265;18&#x0202f;years; (iii) diagnosis of NAFLD confirmed by imaging or liver tissue biopsy.</p><p>Intervention (I): The intervention was to employ at least one dietary polyphenol available in the Phenol-Explorer 3.6 database (database on polyphenol content in foods).<xref rid="fn0002" ref-type="fn"><sup>2</sup></xref></p><p>Comparison (C): The control intervention was placebo or any of the dietary polyphenols available in the Phenol-Explorer 3.6 database.</p><p>Outcomes (O): At least one of the following outcomes must be included: anthropometric measures, including weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), systolic blood pressure (SBP), and diastolic blood pressure (DBP); liver function measures, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT); blood lipid metabolism measures, like triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C); insulin resistance (IR) measures, including fasting blood glucose (FBG), insulin, and homeostasis model assessment of IR; inflammation markers, like necrosis factor alpha (TNF-&#x003b1;).</p><p>Study design (S): RCTs.</p><p>The language was limited to English.</p></sec><sec id="sec10"><label>2.4</label><title>Exclusion criteria</title><list list-type="simple"><list-item><p>(i) Studies with duplicate publications, repeated populations, and unavailable outcome measures.</p></list-item><list-item><p>(ii) Studies focusing on NAFLD with diabetes mellitus (DM) and other types of chronic liver diseases, such as viral hepatitis.</p></list-item><list-item><p>(iii) Studies where the intervention involved a particular food but did not clearly define the dietary polyphenol active ingredients, or where the list of these ingredients was too extensive for mechanism analysis; or studies that included dietary polyphenol supplements alongside western drugs (such metformin) or antioxidants (such as vitamin E).</p></list-item><list-item><p>(iv) Studies excluding the outcome measures covered in this study.</p></list-item><list-item><p>(v) Studies with insufficient data.</p></list-item><list-item><p>(vi) Animal or cell experiments, case reports, scientific experiment programs, reviews, letters, editorials, and conference papers.</p></list-item></list></sec><sec id="sec11"><label>2.5</label><title>Data extraction</title><p>Study screening and management were carried out by means of Endnote X9 software. Two authors (XiaW and LS) initially excluded studies that did not meet the inclusion criteria based on the titles and abstracts, then further searched for and read the full texts to make a final decision on inclusion. Data extraction was independently carried out by the two authors using a pre-created standardized electronic form, where the following key data were extracted and recorded: dietary polyphenols, title, first author, region, publication year, sample size, sex ratio, age, intervention, treatment duration, and outcome measures. To guarantee the accuracy of the data, all extracted data were input into Excel. Any disputed issues during the data extraction process were resolved through discussion between the two authors, with the involvement of a third author (XinW) when necessary.</p></sec><sec id="sec12"><label>2.6</label><title>Quality evaluation</title><p>Using the Cochrane risk of bias tool (ROB 2.0), the quality of each RCT included was appraised sequentially in five areas (<xref rid="ref17" ref-type="bibr">17</xref>): (i) bias from the randomization process, (ii) bias from the intended intervention-intervention allocation, (iii) bias for missing outcome data, (iv) bias for outcome measurement, and (v) bias for selective reporting of results. The relevant response options were selected for each domain namely: yes, probably yes, probably no, no, and no information. These options were distinctly categorized as low risk of bias (ROB), moderate ROB, and high ROB. In the final quality evaluation, a study was deemed to have a low risk of bias (ROB) if all five domains indicated low ROB. If no more than three domains showed some ROB, it was classified as having a moderate ROB. A study with any domain identified as high ROB was considered to have a high ROB. The work was independently done by two authors (XiaW and XinW), and any differences were settled with a third author (LS).</p></sec><sec id="sec13"><label>2.7</label><title>Statistical analysis</title><p>All variables were expressed as mean &#x000b1; standard deviation, with effect sizes measured by means of weighted mean difference (WMD) or standardized mean difference. When a study employed the same dietary polyphenol intervention with varying doses, only noticeable efficacy data was included in the NMA. When a study had two dietary polyphenol interventions, they were considered separate studies and included in the NMA. If certain studies were potentially or definitively derived from the same clinical trial registry, they may be included in the NMA, provided that duplicate outcome measures were excluded.</p><p>In this study, the Markov Chain Monte Carlo method was leveraged to create a Bayesian NMA model (<xref rid="ref18" ref-type="bibr">18</xref>), which was iterated to estimate the relative efficacy of various dietary polyphenols. During testing, the model chain was set to 4, annealing to 10,000, iterations to 50,000, with a step size of 1 and an initial value of 2.5. This procedure was designed to obtain the posterior distribution.</p><p>To choose an appropriate effect model, heterogeneity among the included studies was appraised employing the <italic>I</italic><sup>2</sup> statistic. If <italic>I</italic><sup>2</sup>&#x0202f;&#x02264;&#x0202f;50%, indicating moderate heterogeneity across studies (<xref rid="ref19" ref-type="bibr">19</xref>), the Bayesian fixed-effect NMA model was employed. In contrast, the Bayesian random-effects NMA model was applied (<xref rid="ref20" ref-type="bibr">20</xref>). In this way, the overall effect size could be estimated more accurately. Since the study results did not form a closed loop, an inconsistency test was not executed.</p><p>Simultaneously, a network diagram was plotted to intuitively display the links among various polyphenol interventions for NAFLD. Finally, the surface under the cumulative ranking curve (SUCRA) was calculated (<xref rid="ref21" ref-type="bibr">21</xref>), allowing for a ranking of the therapeutic effects of each polyphenol. Additionally, a publication bias test was executed. Funnel plots were leveraged to appraise the potential for publication bias (<xref rid="ref22" ref-type="bibr">22</xref>), thereby ensuring the impartiality and thoroughness of the analysis results.</p><p>R (version 4.3.2) was leveraged to build the Bayesian NMA model, perform heterogeneity tests, and calculate SUCRA. Network diagrams and funnel plots were created by means of Stata (version 15.1). <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05 was deemed statistically significant.</p></sec></sec><sec sec-type="results" id="sec14"><label>3</label><title>Results</title><sec id="sec15"><label>3.1</label><title>Study selection</title><p>In total, 6,801 articles were retrieved from the above databases. Endnote X9 was leveraged to search for study titles with terms such as &#x0201c;animal&#x0201d; &#x0201c;mouse&#x0201d; &#x0201c;cell&#x0201d; &#x0201c;review&#x0201d; &#x0201c;abstract&#x0201d; and &#x0201c;network pharmacology&#x0201d; to exclude non-RCTs. Through examining the abstracts, other studies that did not meet the inclusion criteria were excluded, leaving 117 articles. Upon reading the entire text, further screening was executed on the PICOS framework. Among the 117 articles, 2 were non-RCTs, 34 had interventions in the treatment or control groups that did not meet the inclusion criteria, 11 involved participants with NAFLD combined with DM or pediatric NAFLD, and 16 had no available outcome measures. Ultimately, 54 articles were included in the NMA, and the detailed screening procedure is depicted in <xref rid="fig1" ref-type="fig">Figure 1</xref>.</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Literature screening flow chart.</p></caption><graphic xlink:href="fnut-12-1582861-g001" position="float"/></fig></sec><sec id="sec16"><label>3.2</label><title>Basic characteristics and quality assessment of the included studies</title><p>The basic characteristics of the studies included are available in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 2</xref>. In total, 54 RCTs were included (<xref rid="ref23" ref-type="bibr">23</xref>&#x02013;<xref rid="ref76" ref-type="bibr">76</xref>), involving 3,132 participants aged 18 to 70&#x0202f;years. Males represented approximately 56.84%, and females accounted for approximately 45.56%. Forty-four studies were conducted in Iran, 3 in China, 2 in India, and 1 each in Australia, Denmark, Japan, Malaysia, and Pakistan. The type of intervention was dietary polyphenol supplements or diets containing certain dietary polyphenol active ingredients. Curcumin was employed in 18 studies, resveratrol in 8, anthocyanin in 5, silymarin in 6, catechin in 4, CA in 4, EA in 2, genistin/genistein in 2, naringenin in 2, DHM in 1, hesperidin in 1, quercetin in 1, and GA and CA in 1.</p><p>The results of the quality evaluation are available in <xref rid="fig2" ref-type="fig">Figure 2</xref>. Out of the studies, 9 (16.66%) were high risk, 25 (46.30%) were low risk, and 20 (37.04%) had some risk. Among the nine high-risk studies, six had a dropout rate over 10% (<xref rid="ref27" ref-type="bibr">27</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref50" ref-type="bibr">50</xref>, <xref rid="ref62" ref-type="bibr">62</xref>, <xref rid="ref67" ref-type="bibr">67</xref>, <xref rid="ref75" ref-type="bibr">75</xref>), and three had a dropout rate over 10% and did not employ a double-blind approach (<xref rid="ref32" ref-type="bibr">32</xref>, <xref rid="ref33" ref-type="bibr">33</xref>, <xref rid="ref56" ref-type="bibr">56</xref>).</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Quality evaluation of included studies.</p></caption><graphic xlink:href="fnut-12-1582861-g002" position="float"/></fig></sec><sec id="sec17"><label>3.3</label><title>NMA results</title><sec id="sec18"><label>3.3.1</label><title>Network diagram</title><p><xref rid="fig3" ref-type="fig">Figure 3</xref> displays the network diagrams of outcome measures (such as BMI) in the treatment of NAFLD with various dietary polyphenols. Each node in the diagram represented a polyphenol or placebo, and the connecting line between two nodes represented a direct comparison of two polyphenols or any polyphenol with a placebo. The size of each node and the width of the connecting line were proportional to the number of studies (<xref rid="ref22" ref-type="bibr">22</xref>). The network diagrams of other outcome measures can be found in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 3</xref>.</p><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Network relationship diagram of different outcome indicators in NAFLD patients treated with different dietary polyphenol supplements. <bold>(A)</bold> BMI; <bold>(B)</bold> ALT; <bold>(C)</bold> AST; <bold>(D)</bold> TC; <bold>(E)</bold> TG; <bold>(F)</bold> HDL-C; <bold>(G)</bold> LDL-C; <bold>(H)</bold> TNF-&#x003b1;.</p></caption><graphic xlink:href="fnut-12-1582861-g003" position="float"/></fig></sec><sec id="sec19"><label>3.3.2</label><title>SUCRA plot</title><p>The SUCRA varied from 0 to 100%. A larger SUCRA indicated that the dietary polyphenol was ranked higher compared to other polyphenols and was more effective in treating NAFLD. <xref rid="fig4" ref-type="fig">Figure 4</xref> displays the SUCRAs for outcome measures, including BMI, following the treatment of NAFLD with various dietary polyphenol supplements. The SUCRAs for other outcome measures are provided in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 3</xref>.</p><fig position="float" id="fig4"><label>Figure 4</label><caption><p>SUCRA diagram of changes in different outcome indicators caused by different dietary polyphenol supplements in the treatment of NAFLD. <bold>(A)</bold> BMI; <bold>(B)</bold> ALT; <bold>(C)</bold> AST; <bold>(D)</bold> TC; <bold>(E)</bold> TG; <bold>(F)</bold> HDL-C; <bold>(G)</bold> LDL-C; <bold>(H)</bold> TNF-&#x003b1;.</p></caption><graphic xlink:href="fnut-12-1582861-g004" position="float"/></fig></sec><sec id="sec20"><label>3.3.3</label><title>Anthropometric outcome measures</title><p>The anthropometric outcome measures included weight, BMI, WHR, WC, HC, SBP, and DBP, with 34 studies reporting BMI. The NMA results of weight, WC, HC, WHR, SBP, and DBP are available in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 3</xref>.</p><p>The NMA results exhibited no marked differences in BMI changes induced by these dietary polyphenols (<xref rid="tab1" ref-type="table">Table 1</xref>). According to the SUCRA probability ranking for BMI reduction, catechin (77.74%) was ranked highest, followed by EA (74.29%) and quercetin (51.58%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>League table of BMI of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">EA</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.99 (&#x02212;5.66, 1.66)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.16 (&#x02212;3.96, 3.63)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.43 (&#x02212;4.34, 3.45)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.44 (&#x02212;4.05, 3.18)</td><td align="center" valign="top" rowspan="1" colspan="1">0.67 (&#x02212;0.89, 2.22)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.49 (&#x02212;5.53, 4.56)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.05 (&#x02212;4.76, 0.7)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.37 (&#x02212;2.92, 2.15)</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 (&#x02212;5.02, 5.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.04 (&#x02212;2.96, 3.04)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.56 (&#x02212;5.57, 4.45)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.99 (&#x02212;1.66, 5.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">EA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.83 (&#x02212;3.41, 7.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.55 (&#x02212;3.78, 6.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.55 (&#x02212;3.59, 6.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.67 (&#x02212;1.32, 6.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5 (&#x02212;4.75, 7.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.05 (&#x02212;4.59, 4.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.61 (&#x02212;2.83, 6.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.05 (&#x02212;4.2, 8.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.04 (&#x02212;2.69, 6.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.43 (&#x02212;4.76, 7.66)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.16 (&#x02212;3.63, 3.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.83 (&#x02212;7.11, 3.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.28 (&#x02212;5.72, 5.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.28 (&#x02212;5.52, 4.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.83 (&#x02212;3.28, 4.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.33 (&#x02212;6.66, 5.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.88 (&#x02212;6.57, 2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22 (&#x02212;4.77, 4.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21 (&#x02212;6.12, 6.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 (&#x02212;4.66, 5.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.41 (&#x02212;6.7, 5.89)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.43 (&#x02212;3.45, 4.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.55 (&#x02212;6.9, 3.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28 (&#x02212;5.14, 5.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.01 (&#x02212;5.3, 5.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1 (&#x02212;3.08, 5.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.06 (&#x02212;6.41, 6.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.61 (&#x02212;6.36, 3.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 (&#x02212;4.58, 4.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49 (&#x02212;5.88, 6.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47 (&#x02212;4.42, 5.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13 (&#x02212;6.46, 6.19)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.44 (&#x02212;3.18, 4.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.55 (&#x02212;6.71, 3.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28 (&#x02212;4.97, 5.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01 (&#x02212;5.32, 5.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.12 (&#x02212;2.83, 5.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.04 (&#x02212;6.24, 6.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.6 (&#x02212;6.14, 2.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 (&#x02212;4.36, 4.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 (&#x02212;5.74, 6.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49 (&#x02212;4.22, 5.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13 (&#x02212;6.31, 6.04)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.67 (&#x02212;2.22, 0.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.67 (&#x02212;6.64, 1.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.83 (&#x02212;4.94, 3.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.1 (&#x02212;5.3, 3.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.12 (&#x02212;5.03, 2.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.17 (&#x02212;6.43, 4.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.72 (&#x02212;5.83, 0.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.04 (&#x02212;4.03, 1.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.62 (&#x02212;5.9, 4.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.63 (&#x02212;4.01, 2.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.23 (&#x02212;6.48, 4.01)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.49 (&#x02212;4.56, 5.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.5 (&#x02212;7.74, 4.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33 (&#x02212;5.99, 6.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 (&#x02212;6.33, 6.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04 (&#x02212;6.16, 6.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17 (&#x02212;4.11, 6.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.56 (&#x02212;7.29, 4.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11 (&#x02212;5.52, 5.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.55 (&#x02212;6.57, 7.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54 (&#x02212;5.36, 6.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.07 (&#x02212;7.18, 7.05)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.05 (&#x02212;0.7, 4.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 (&#x02212;4.55, 4.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.88 (&#x02212;2.8, 6.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.61 (&#x02212;3.14, 6.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 (&#x02212;2.94, 6.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.72 (&#x02212;0.44, 5.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56 (&#x02212;4.18, 7.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">1.66 (&#x02212;2.07, 5.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.11 (&#x02212;3.67, 7.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.09 (&#x02212;1.98, 6.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.48 (&#x02212;4.23, 7.21)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.37 (&#x02212;2.15, 2.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.61 (&#x02212;6.07, 2.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 (&#x02212;4.36, 4.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.05 (&#x02212;4.7, 4.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.06 (&#x02212;4.49, 4.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.04 (&#x02212;1.91, 4.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.11 (&#x02212;5.76, 5.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.66 (&#x02212;5.39, 2.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44 (&#x02212;5.26, 6.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42 (&#x02212;3.52, 4.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.19 (&#x02212;5.79, 5.43)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.06 (&#x02212;5.1, 5.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.05 (&#x02212;8.3, 4.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.21 (&#x02212;6.56, 6.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.49 (&#x02212;6.87, 5.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.5 (&#x02212;6.71, 5.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.62 (&#x02212;4.68, 5.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.55 (&#x02212;7.64, 6.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.11 (&#x02212;7.83, 3.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.44 (&#x02212;6.07, 5.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;5.92, 5.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.63 (&#x02212;7.76, 6.52)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.04 (&#x02212;3.04, 2.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.04 (&#x02212;6.77, 2.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.2 (&#x02212;5.03, 4.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.47 (&#x02212;5.41, 4.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.49 (&#x02212;5.17, 4.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.63 (&#x02212;2.74, 4.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.54 (&#x02212;6.42, 5.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.09 (&#x02212;6.12, 1.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.42 (&#x02212;4.33, 3.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 (&#x02212;5.88, 5.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;6.45, 5.25)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.56 (&#x02212;4.45, 5.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.43 (&#x02212;7.66, 4.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41 (&#x02212;5.89, 6.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13 (&#x02212;6.19, 6.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13 (&#x02212;6.04, 6.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23 (&#x02212;4.01, 6.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07 (&#x02212;7.05, 7.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.48 (&#x02212;7.21, 4.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 (&#x02212;5.43, 5.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.63 (&#x02212;6.52, 7.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;5.25, 6.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</p></table-wrap-foot></table-wrap></sec><sec id="sec21"><label>3.3.4</label><title>Liver function-related outcome measures</title><p>Liver function-related outcome measures included ALT, AST, ALP, and GGT. ALT was reported in 42 studies, and AST in 41 studies. The NMA results of ALP and GGT can be found in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 3</xref>.</p><p>The NMA results revealed that catechin was more effective than placebo [WMD&#x0202f;=&#x0202f;19.14, 95% confidence interval (CI)&#x0202f;=&#x0202f;(8.87, 29.32)], curcumin [WMD&#x0202f;=&#x0202f;12.93, 95% CI&#x0202f;=&#x0202f;(1.51, 24.24)], and resveratrol [WMD&#x0202f;=&#x0202f;&#x02212;15.39, 95% CI&#x0202f;=&#x0202f;(&#x02212;29.17, &#x02212;1.55)] in reducing ALT. Additional results with differences are provided in <xref rid="tab2" ref-type="table">Table 2</xref>. The SUCRA probability ranking for reducing serum ALT revealed that catechin (94.21%) was the most effective, followed by silymarin (74.76%) and DHM (70.86%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>League table of ALT of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.44 (&#x02212;16.44, 1.79)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.24 (&#x02212;17.82, 9.39)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.46 (&#x02212;17.12, 8.44)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;6.21 (&#x02212;11.18, &#x02212;1.23)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;19.14 (&#x02212;29.32, &#x02212;8.87)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.75 (&#x02212;13.06, 5.6)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;11.73 (&#x02212;28.77, 5.54)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.74 (&#x02212;17.49, 16.05)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;11.11 (&#x02212;19.06, &#x02212;3.43)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;6.15 (&#x02212;23.03, 10.67)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.35 (&#x02212;18.39, 17.67)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.43 (&#x02212;19.1, 14.24)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7.44 (&#x02212;1.79, 16.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2 (&#x02212;13.31, 19.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.96 (&#x02212;12.77, 18.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.22 (&#x02212;9.28, 11.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.72 (&#x02212;25.46, 1.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7 (&#x02212;9.44, 16.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.29 (&#x02212;23.79, 15.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.69 (&#x02212;12.56, 25.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.69 (&#x02212;15.91, 8.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28 (&#x02212;18.05, 20.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.09 (&#x02212;13.3, 27.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.98 (&#x02212;14.11, 23.9)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.24 (&#x02212;9.39, 17.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.2 (&#x02212;19.53, 13.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25 (&#x02212;18.78, 18.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.98 (&#x02212;16.47, 12.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.87 (&#x02212;31.91, 2.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44 (&#x02212;16, 17.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.5 (&#x02212;29.26, 14.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 (&#x02212;18.04, 25.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.9 (&#x02212;22.72, 8.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.93 (&#x02212;23.54, 19.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.82 (&#x02212;18.59, 26.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.79 (&#x02212;19.75, 23.47)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.46 (&#x02212;8.44, 17.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.96 (&#x02212;18.72, 12.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 (&#x02212;18.64, 18.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.74 (&#x02212;15.6, 11.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.68 (&#x02212;31.07, 1.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.71 (&#x02212;15.18, 16.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.24 (&#x02212;28.81, 14.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.72 (&#x02212;17.52, 24.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.67 (&#x02212;21.91, 8.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.7 (&#x02212;23.18, 19.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.12 (&#x02212;18.13, 26.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.02 (&#x02212;19.3, 22.99)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>6.21 (1.23, 11.18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.22 (&#x02212;11.51, 9.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.98 (&#x02212;12.47, 16.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.74 (&#x02212;11.88, 15.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;12.93 (&#x02212;24.24, &#x02212;1.51)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.45 (&#x02212;8.1, 13.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.51 (&#x02212;23.28, 12.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.47 (&#x02212;11.95, 22.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.91 (&#x02212;14.28, 4.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 (&#x02212;17.49, 17.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.86 (&#x02212;12.89, 24.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.74 (&#x02212;13.64, 21.17)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>19.14 (8.87, 29.32)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11.72 (&#x02212;1.96, 25.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.87 (&#x02212;2.12, 31.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.68 (&#x02212;1.63, 31.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>12.93 (1.51, 24.24)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>15.39 (1.55, 29.17)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.45 (&#x02212;12.62, 27.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.43 (&#x02212;1.24, 38)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.03 (&#x02212;5.01, 20.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.98 (&#x02212;6.8, 32.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.79 (&#x02212;1.98, 39.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">16.71 (&#x02212;2.89, 36.18)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3.75 (&#x02212;5.6, 13.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.7 (&#x02212;16.74, 9.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.44 (&#x02212;17.08, 16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.71 (&#x02212;16.48, 15.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.45 (&#x02212;13.01, 8.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;15.39 (&#x02212;29.17, &#x02212;1.55)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.97 (&#x02212;27.44, 11.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.99 (&#x02212;16.25, 22.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.38 (&#x02212;19.7, 4.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.41 (&#x02212;21.81, 16.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.41 (&#x02212;16.96, 23.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29 (&#x02212;17.83, 20.42)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">11.73 (&#x02212;5.54, 28.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.29 (&#x02212;15.14, 23.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5 (&#x02212;14.51, 29.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.24 (&#x02212;14.11, 28.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.51 (&#x02212;12.38, 23.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.45 (&#x02212;27.28, 12.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.97 (&#x02212;11.57, 27.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">10.96 (&#x02212;13.06, 34.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;18.48, 19.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.59 (&#x02212;18.67, 29.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.33 (&#x02212;13.61, 36.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.24 (&#x02212;14.75, 33.15)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.74 (&#x02212;16.05, 17.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.69 (&#x02212;25.68, 12.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.5 (&#x02212;25.09, 18.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.72 (&#x02212;24.65, 17.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.47 (&#x02212;22.96, 11.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.43 (&#x02212;38, 1.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.99 (&#x02212;22.19, 16.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.96 (&#x02212;34.91, 13.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.4 (&#x02212;28.98, 7.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.44 (&#x02212;29.27, 18.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37 (&#x02212;24.24, 24.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.7 (&#x02212;25.34, 21.9)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>11.11 (3.43, 19.06)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.69 (&#x02212;8.16, 15.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.9 (&#x02212;8.74, 22.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.67 (&#x02212;8.1, 21.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.91 (&#x02212;4.22, 14.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.03 (&#x02212;20.72, 5.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.38 (&#x02212;4.69, 19.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;19.24, 18.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.4 (&#x02212;7.99, 28.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">4.95 (&#x02212;13.56, 23.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.77 (&#x02212;8.76, 30.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.68 (&#x02212;9.59, 27.18)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">6.15 (&#x02212;10.67, 23.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.28 (&#x02212;20.27, 18.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.93 (&#x02212;19.82, 23.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 (&#x02212;19.37, 23.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.05 (&#x02212;17.58, 17.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.98 (&#x02212;32.65, 6.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.41 (&#x02212;16.84, 21.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.59 (&#x02212;29.51, 18.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.44 (&#x02212;18.33, 29.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.95 (&#x02212;23.68, 13.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">5.82 (&#x02212;18.83, 30.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.69 (&#x02212;20.05, 27.62)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.35 (&#x02212;17.67, 18.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.09 (&#x02212;27.15, 13.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.82 (&#x02212;26.56, 18.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.12 (&#x02212;26.14, 18.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.86 (&#x02212;24.53, 12.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.79 (&#x02212;39.4, 1.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.41 (&#x02212;23.72, 16.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.33 (&#x02212;36.33, 13.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.37 (&#x02212;24.96, 24.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.77 (&#x02212;30.51, 8.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.82 (&#x02212;30.5, 18.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.07 (&#x02212;26.66, 22.44)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.43 (&#x02212;14.24, 19.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.98 (&#x02212;23.9, 14.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.79 (&#x02212;23.47, 19.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.02 (&#x02212;22.99, 19.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.74 (&#x02212;21.17, 13.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;16.71 (&#x02212;36.18, 2.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.29 (&#x02212;20.42, 17.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.24 (&#x02212;33.15, 14.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 (&#x02212;21.9, 25.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.68 (&#x02212;27.18, 9.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.69 (&#x02212;27.62, 20.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.07 (&#x02212;22.44, 26.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap><p>Catechin demonstrated superior efficacy in lowering AST relative to placebo [WMD&#x0202f;=&#x0202f;12.37, 95% CI&#x0202f;=&#x0202f;(4.68, 19.71)], curcumin [WMD&#x0202f;=&#x0202f;9.32, 95% CI&#x0202f;=&#x0202f;(1.1, 17.2)], resveratrol [WMD&#x0202f;=&#x0202f;&#x02212;9.5, 95% CI&#x0202f;=&#x0202f;(&#x02212;18.62, &#x02212;0.06)], naringenin [WMD&#x0202f;=&#x0202f;&#x02212;12.77, 95% CI&#x0202f;=&#x0202f;(&#x02212;24.56, &#x02212;0.51)], and hesperidin [WMD&#x0202f;=&#x0202f;&#x02212;15.23, 95% CI&#x0202f;=&#x0202f;(&#x02212;27.67, &#x02212;2.37)]. Additional results with differences are provided in <xref rid="tab3" ref-type="table">Table 3</xref>. For lowering serum AST, the SUCRA probability ranking showed catechin (93.56%) as the highest, followed by silymarin (78.37%) and GA and CA (68.49%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab3"><label>Table 3</label><caption><p>League table of AST of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;5.02 (&#x02212;10.33, 0.16)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.78 (&#x02212;9.32, 5.87)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.4 (&#x02212;10.86, 6.04)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;3.05 (&#x02212;5.88, &#x02212;0.24)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;12.37 (&#x02212;19.71, &#x02212;4.68)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.87 (&#x02212;8.29, 2.59)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;6.05 (&#x02212;15.79, 3.71)</td><td align="center" valign="top" rowspan="1" colspan="1">0.36 (&#x02212;9.04, 9.77)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;7.7 (&#x02212;12.26, &#x02212;2.98)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;6.82 (&#x02212;16.71, 3.18)</td><td align="center" valign="top" rowspan="1" colspan="1">2.87 (&#x02212;7.24, 12.93)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.05 (&#x02212;13.72, 5.63)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5.02 (&#x02212;0.16, 10.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">3.25 (&#x02212;5.89, 12.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.62 (&#x02212;7.34, 12.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.96 (&#x02212;3.93, 7.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.35 (&#x02212;16.33, 2.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.16 (&#x02212;5.35, 9.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.02 (&#x02212;12.04, 10.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.38 (&#x02212;5.32, 16.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.68 (&#x02212;9.53, 4.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.79 (&#x02212;12.94, 9.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.88 (&#x02212;3.46, 19.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.96 (&#x02212;9.96, 12.08)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.78 (&#x02212;5.87, 9.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.25 (&#x02212;12.56, 5.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;12.02, 10.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.28 (&#x02212;9.48, 6.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.6 (&#x02212;21.17, 0.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.08 (&#x02212;10.4, 8.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.26 (&#x02212;16.7, 8.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.15 (&#x02212;10.04, 14.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.91 (&#x02212;14.75, 3.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.03 (&#x02212;17.55, 7.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.64 (&#x02212;8.06, 17.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.28 (&#x02212;14.67, 10)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.4 (&#x02212;6.04, 10.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.62 (&#x02212;12.61, 7.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;10.63, 12.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.66 (&#x02212;9.53, 8.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.97 (&#x02212;21.11, 1.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.47 (&#x02212;10.47, 9.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.63 (&#x02212;16.54, 9.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.76 (&#x02212;9.83, 15.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.28 (&#x02212;14.83, 4.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.41 (&#x02212;17.39, 8.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.26 (&#x02212;7.82, 18.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.65 (&#x02212;14.43, 11.21)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>3.05 (0.24, 5.88)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.96 (&#x02212;7.98, 3.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28 (&#x02212;6.76, 9.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.66 (&#x02212;8.23, 9.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;9.32 (&#x02212;17.2, &#x02212;1.1)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 (&#x02212;5.92, 6.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.99 (&#x02212;13.14, 7.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.43 (&#x02212;6.39, 13.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.64 (&#x02212;9.98, 0.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.77 (&#x02212;14.05, 6.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.91 (&#x02212;4.56, 16.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1 (&#x02212;11.08, 9.06)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>12.37 (4.68, 19.71)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.35 (&#x02212;2.09, 16.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.6 (&#x02212;0.19, 21.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.97 (&#x02212;1.58, 21.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.32 (1.1, 17.2)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.5 (0.06, 18.62)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.35 (&#x02212;6.23, 18.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>12.77 (0.51, 24.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.68 (&#x02212;4.22, 13.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.57 (&#x02212;7.07, 17.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>15.23 (2.37, 27.67)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.32 (&#x02212;4.18, 20.33)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.87 (&#x02212;2.59, 8.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.16 (&#x02212;9.81, 5.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.08 (&#x02212;8.29, 10.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47 (&#x02212;9.65, 10.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.19 (&#x02212;6.34, 5.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;9.5 (&#x02212;18.62, &#x02212;0.06)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.18 (&#x02212;14.45, 7.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.24 (&#x02212;7.66, 14.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.83 (&#x02212;11.92, 2.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.96 (&#x02212;15.28, 7.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.74 (&#x02212;5.78, 17.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.19 (&#x02212;12.35, 9.87)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">6.05 (&#x02212;3.71, 15.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02 (&#x02212;10.06, 12.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.26 (&#x02212;8.07, 16.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.63 (&#x02212;9.35, 16.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.99 (&#x02212;7.2, 13.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.35 (&#x02212;18.42, 6.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.18 (&#x02212;7.99, 14.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4 (&#x02212;7.13, 19.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.65 (&#x02212;12.38, 9.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.76 (&#x02212;14.66, 13.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.89 (&#x02212;5.22, 22.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.99 (&#x02212;11.71, 15.74)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.36 (&#x02212;9.77, 9.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.38 (&#x02212;16.2, 5.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.15 (&#x02212;14.15, 10.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.76 (&#x02212;15.5, 9.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.43 (&#x02212;13.24, 6.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;12.77 (&#x02212;24.56, &#x02212;0.51)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.24 (&#x02212;14.01, 7.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.4 (&#x02212;19.94, 7.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.08 (&#x02212;18.47, 2.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.16 (&#x02212;20.83, 6.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.47 (&#x02212;11.26, 16.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.4 (&#x02212;17.92, 9.1)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>7.7 (2.98, 12.26)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.68 (&#x02212;4.44, 9.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.91 (&#x02212;3.05, 14.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.28 (&#x02212;4.46, 14.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.64 (&#x02212;0.88, 9.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.68 (&#x02212;13.35, 4.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.83 (&#x02212;2.36, 11.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.65 (&#x02212;9.18, 12.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.08 (&#x02212;2.51, 18.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.88 (&#x02212;10.1, 11.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.56 (&#x02212;0.61, 21.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.64 (&#x02212;7.16, 14.26)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">6.82 (&#x02212;3.18, 16.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.79 (&#x02212;9.51, 12.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.03 (&#x02212;7.44, 17.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.41 (&#x02212;8.71, 17.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.77 (&#x02212;6.62, 14.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.57 (&#x02212;17.87, 7.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.96 (&#x02212;7.33, 15.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.76 (&#x02212;13.18, 14.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.16 (&#x02212;6.53, 20.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.88 (&#x02212;11.8, 10.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">9.69 (&#x02212;4.56, 23.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.76 (&#x02212;11.06, 16.63)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;2.87 (&#x02212;12.93, 7.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.88 (&#x02212;19.31, 3.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.64 (&#x02212;17.2, 8.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.26 (&#x02212;18.49, 7.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.91 (&#x02212;16.41, 4.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;15.23 (&#x02212;27.67, &#x02212;2.37)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.74 (&#x02212;17.13, 5.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.89 (&#x02212;22.96, 5.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.47 (&#x02212;16.25, 11.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.56 (&#x02212;21.57, 0.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.69 (&#x02212;23.78, 4.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.93 (&#x02212;20.86, 7.1)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.05 (&#x02212;5.63, 13.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.96 (&#x02212;12.08, 9.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.28 (&#x02212;10, 14.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.65 (&#x02212;11.21, 14.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (&#x02212;9.06, 11.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.32 (&#x02212;20.33, 4.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19 (&#x02212;9.87, 12.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.99 (&#x02212;15.74, 11.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.4 (&#x02212;9.1, 17.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.64 (&#x02212;14.26, 7.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.76 (&#x02212;16.63, 11.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.93 (&#x02212;7.1, 20.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap></sec><sec id="sec22"><label>3.3.5</label><title>Blood lipid-related outcome measures</title><p>Blood lipid-related outcome measures involved TC, TG, HDL-C, and LDL-C. Thirty-five studies reported TC, TG, HDL-C, and LDL-C each.</p><p>According to the NMA results, naringenin outperformed placebo [WMD&#x0202f;=&#x0202f;32.84, 95% CI&#x0202f;=&#x0202f;(14.31, 51.46)], EA [WMD&#x0202f;=&#x0202f;19.11, 95% CI&#x0202f;=&#x0202f;(0.56, 37.74)], anthocyanin [WMD&#x0202f;=&#x0202f;32.65, 95% CI&#x0202f;=&#x0202f;(11.93, 53.47)], genistin/genistein [WMD&#x0202f;=&#x0202f;31.34, 95% CI&#x0202f;=&#x0202f;(5.24, 57.52)], CA [WMD&#x0202f;=&#x0202f;23.33, 95% CI&#x0202f;=&#x0202f;(0.84, 45.79)], curcumin [WMD&#x0202f;=&#x0202f;25.26, 95% CI&#x0202f;=&#x0202f;(6.52, 44.09)], resveratrol [WMD&#x0202f;=&#x0202f;&#x02212;27.86, 95% CI&#x0202f;=&#x0202f;(&#x02212;48.1, &#x02212;7.7)], DHM [WMD&#x0202f;=&#x0202f;&#x02212;23.55, 95% CI&#x0202f;=&#x0202f;(&#x02212;45.81, &#x02212;1.34)], silymarin [WMD&#x0202f;=&#x0202f;&#x02212;24.29, 95% CI&#x0202f;=&#x0202f;(&#x02212;44.68, &#x02212;3.99)], and quercetin [WMD&#x0202f;=&#x0202f;&#x02212;24.13, 95% CI&#x0202f;=&#x0202f;(&#x02212;47.01, &#x02212;1.39)] in reducing TC. Catechin exhibited superior efficacy in lowering TC relative to placebo [WMD&#x0202f;=&#x0202f;28.44, 95% CI&#x0202f;=&#x0202f;(19.52, 37.29)], EA [WMD&#x0202f;=&#x0202f;14.71, 95% CI&#x0202f;=&#x0202f;(5.78, 23.58)], anthocyanin [WMD&#x0202f;=&#x0202f;28.29, 95% CI&#x0202f;=&#x0202f;(15.41, 41.13)], genistin/genistein [WMD&#x0202f;=&#x0202f;26.99, 95% CI&#x0202f;=&#x0202f;(6.53, 47.44)], CA [WMD&#x0202f;=&#x0202f;18.94, 95% CI&#x0202f;=&#x0202f;(3.51, 34.39)], curcumin [WMD&#x0202f;=&#x0202f;20.86, 95% CI&#x0202f;=&#x0202f;(11.56, 30.12)], resveratrol [WMD&#x0202f;=&#x0202f;&#x02212;23.46, 95% CI&#x0202f;=&#x0202f;(&#x02212;35.41, &#x02212;11.52)], DHM [WMD&#x0202f;=&#x0202f;&#x02212;19.12, 95% CI&#x0202f;=&#x0202f;(&#x02212;34.18, &#x02212;4.02)], silymarin [WMD&#x0202f;=&#x0202f;&#x02212;19.93, 95% CI&#x0202f;=&#x0202f;(&#x02212;31.95, &#x02212;7.79)], and quercetin [WMD&#x0202f;=&#x0202f;&#x02212;19.76, 95% CI&#x0202f;=&#x0202f;(&#x02212;35.56, &#x02212;3.88)]. More results with differences are presented in <xref rid="tab4" ref-type="table">Table 4</xref>. The SUCRA probability ranking for lowering serum TC demonstrated that naringenin (94.59%) was the most effective, followed by catechin (92.26%) and GA and CA (83.52%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab4"><label>Table 4</label><caption><p>League table of TC of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">EA</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;13.73 (&#x02212;14.12, &#x02212;13.34)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.15 (&#x02212;9.51, 9.19)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.45 (&#x02212;19.94, 16.93)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;9.48 (&#x02212;22.21, 3.12)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;7.58 (&#x02212;10.28, &#x02212;4.89)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;32.84 (&#x02212;51.46, &#x02212;14.31)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;28.44 (&#x02212;37.29, &#x02212;19.52)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.99 (&#x02212;12.97, 3.01)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;9.31 (&#x02212;21.54, 2.91)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;8.51 (&#x02212;16.74, &#x02212;0.34)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;23.31 (&#x02212;38.98, &#x02212;7.65)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;10.79 (&#x02212;26.41, 4.76)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8.71 (&#x02212;21.91, 4.52)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>13.73 (13.34, 14.12)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">EA</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>13.58 (4.21, 22.93)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.28 (&#x02212;6.2, 30.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.25 (&#x02212;8.47, 16.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6.15 (3.43, 8.87)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;19.11 (&#x02212;37.74, &#x02212;0.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;14.71 (&#x02212;23.58, &#x02212;5.78)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>8.75 (0.76, 16.77)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.42 (&#x02212;7.8, 16.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.22 (&#x02212;3.02, 13.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.58 (&#x02212;25.26, 6.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.95 (&#x02212;12.66, 18.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.03 (&#x02212;8.18, 18.25)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.15 (&#x02212;9.19, 9.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;13.58 (&#x02212;22.93, &#x02212;4.21)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.31 (&#x02212;21.9, 19.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.32 (&#x02212;25.01, 6.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.44 (&#x02212;17.14, 2.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;32.65 (&#x02212;53.47, &#x02212;11.93)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;28.29 (&#x02212;41.13, &#x02212;15.41)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.82 (&#x02212;17.11, 7.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.16 (&#x02212;24.45, 6.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.39 (&#x02212;20.75, 4.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;23.15 (&#x02212;41.33, &#x02212;4.88)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.63 (&#x02212;28.75, 7.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.53 (&#x02212;24.65, 7.66)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.45 (&#x02212;16.93, 19.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.28 (&#x02212;30.67, 6.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.31 (&#x02212;19.29, 21.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.04 (&#x02212;30.42, 14.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.13 (&#x02212;24.7, 12.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;31.34 (&#x02212;57.52, &#x02212;5.24)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;26.99 (&#x02212;47.44, &#x02212;6.53)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.5 (&#x02212;23.61, 16.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.82 (&#x02212;29.91, 14.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.08 (&#x02212;27.22, 13)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;21.81 (&#x02212;45.98, 2.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.33 (&#x02212;33.38, 14.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.25 (&#x02212;29.84, 15.42)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">9.48 (&#x02212;3.12, 22.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.25 (&#x02212;16.87, 8.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.32 (&#x02212;6.33, 25.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.04 (&#x02212;14.33, 30.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.92 (&#x02212;10.99, 14.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;23.33 (&#x02212;45.79, &#x02212;0.84)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;18.94 (&#x02212;34.39, &#x02212;3.51)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5 (&#x02212;10.37, 19.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 (&#x02212;17.4, 17.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.98 (&#x02212;14.09, 16.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.8 (&#x02212;33.9, 6.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.29 (&#x02212;21.42, 18.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81 (&#x02212;17.41, 19.02)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>7.58 (4.89, 10.28)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;6.15 (&#x02212;8.87, &#x02212;3.43)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.44 (&#x02212;2.31, 17.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.13 (&#x02212;12.56, 24.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.92 (&#x02212;14.91, 10.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;25.26 (&#x02212;44.09, &#x02212;6.52)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;20.86 (&#x02212;30.12, &#x02212;11.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.59 (&#x02212;5.82, 11.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.72 (&#x02212;14.25, 10.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.94 (&#x02212;9.6, 7.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.73 (&#x02212;31.61, 0.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.19 (&#x02212;19.04, 12.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.12 (&#x02212;14.58, 12.34)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>32.84 (14.31, 51.46)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19.11 (0.56, 37.74)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>32.65 (11.93, 53.47)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>31.34 (5.24, 57.52)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>23.33 (0.84, 45.79)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>25.26 (6.52, 44.09)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">4.37 (&#x02212;16.15, 25.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>27.86 (7.7, 48.1)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>23.55 (1.34, 45.81)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>24.29 (3.99, 44.68)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">9.53 (&#x02212;14.75, 33.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">22.04 (&#x02212;2.35, 46.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>24.13 (1.39, 47.01)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>28.44 (19.52, 37.29)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>14.71 (5.78, 23.58)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>28.29 (15.41, 41.13)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>26.99 (6.53, 47.44)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>18.94 (3.51, 34.39)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>20.86 (11.56, 30.12)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.37 (&#x02212;25.05, 16.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>23.46 (11.52, 35.41)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19.12 (4.02, 34.18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19.93 (7.79, 31.95)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">5.14 (&#x02212;12.89, 23.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.64 (&#x02212;0.33, 35.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19.76 (3.88, 35.56)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.99 (&#x02212;3.01, 12.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;8.75 (&#x02212;16.77, &#x02212;0.76)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.82 (&#x02212;7.51, 17.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 (&#x02212;16.56, 23.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.5 (&#x02212;19.44, 10.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.59 (&#x02212;11.02, 5.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;27.86 (&#x02212;48.1, &#x02212;7.7)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;23.46 (&#x02212;35.41, &#x02212;11.52)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.33 (&#x02212;18.9, 10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.53 (&#x02212;14.98, 7.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;18.3 (&#x02212;35.99, &#x02212;0.7)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.79 (&#x02212;23.29, 11.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.73 (&#x02212;19.09, 11.75)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">9.31 (&#x02212;2.91, 21.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.42 (&#x02212;16.64, 7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.16 (&#x02212;6.28, 24.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.82 (&#x02212;14.32, 29.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.2 (&#x02212;17.78, 17.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.72 (&#x02212;10.81, 14.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;23.55 (&#x02212;45.81, &#x02212;1.34)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;19.12 (&#x02212;34.18, &#x02212;4.02)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 (&#x02212;10.2, 18.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79 (&#x02212;13.94, 15.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.99 (&#x02212;33.9, 5.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.49 (&#x02212;21.36, 18.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6 (&#x02212;17.34, 18.49)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>8.51 (0.34, 16.74)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.22 (&#x02212;13.4, 3.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.39 (&#x02212;4.09, 20.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.08 (&#x02212;13, 27.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.98 (&#x02212;16.09, 14.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.94 (&#x02212;7.68, 9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;24.29 (&#x02212;44.68, &#x02212;3.99)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;19.93 (&#x02212;31.95, &#x02212;7.79)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.53 (&#x02212;7.88, 14.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.79 (&#x02212;15.37, 13.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.8 (&#x02212;32.41, 3.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.27 (&#x02212;19.93, 15.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.19 (&#x02212;15.66, 15.35)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>23.31 (7.65, 38.98)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">9.58 (&#x02212;6.09, 25.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>23.15 (4.88, 41.33)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">21.81 (&#x02212;2.31, 45.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.8 (&#x02212;6.32, 33.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.73 (&#x02212;0.16, 31.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.53 (&#x02212;33.79, 14.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.14 (&#x02212;23.11, 12.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>18.3 (0.7, 35.99)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">13.99 (&#x02212;5.98, 33.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.8 (&#x02212;3.02, 32.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5 (&#x02212;9.6, 34.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.61 (&#x02212;5.83, 35.01)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">10.79 (&#x02212;4.76, 26.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.95 (&#x02212;18.51, 12.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.63 (&#x02212;7.45, 28.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.33 (&#x02212;14.79, 33.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29 (&#x02212;18.76, 21.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.19 (&#x02212;12.56, 19.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;22.04 (&#x02212;46.13, 2.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.64 (&#x02212;35.56, 0.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.79 (&#x02212;11.59, 23.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.49 (&#x02212;18.28, 21.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.27 (&#x02212;15.32, 19.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.5 (&#x02212;34.64, 9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">2.11 (&#x02212;18.32, 22.52)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">8.71 (&#x02212;4.52, 21.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.03 (&#x02212;18.25, 8.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.53 (&#x02212;7.66, 24.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.25 (&#x02212;15.42, 29.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.81 (&#x02212;19.02, 17.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.12 (&#x02212;12.34, 14.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;24.13 (&#x02212;47.01, &#x02212;1.39)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;19.76 (&#x02212;35.56, &#x02212;3.88)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.73 (&#x02212;11.75, 19.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.6 (&#x02212;18.49, 17.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 (&#x02212;15.35, 15.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.61 (&#x02212;35.01, 5.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.11 (&#x02212;22.52, 18.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap><p>Naringenin outperformed placebo [WMD&#x0202f;=&#x0202f;92.5, 95% CI&#x0202f;=&#x0202f;(58.09, 126.53)], EA [WMD&#x0202f;=&#x0202f;76.18, 95% CI&#x0202f;=&#x0202f;(41.77, 110.18)], anthocyanin [WMD&#x0202f;=&#x0202f;57.46, 95% CI&#x0202f;=&#x0202f;(19.56, 94.86)], CA [WMD&#x0202f;=&#x0202f;54.89, 95% CI&#x0202f;=&#x0202f;(13.59, 95.86)], curcumin [WMD&#x0202f;=&#x0202f;70, 95% CI&#x0202f;=&#x0202f;(35.33, 104.33)], catechin [WMD&#x0202f;=&#x0202f;&#x02212;61.26, 95% CI&#x0202f;=&#x0202f;(&#x02212;96.53, &#x02212;25.7)], resveratrol [WMD&#x0202f;=&#x0202f;&#x02212;90.54, 95% CI&#x0202f;=&#x0202f;(&#x02212;126.58, &#x02212;54.25)], DHM [WMD&#x0202f;=&#x0202f;&#x02212;72.82, 95% CI&#x0202f;=&#x0202f;(&#x02212;120.49, &#x02212;25.32)], silymarin [WMD&#x0202f;=&#x0202f;&#x02212;74.94, 95% CI&#x0202f;=&#x0202f;(&#x02212;110.26, &#x02212;39.23)], GA and CA [WMD&#x0202f;=&#x0202f;&#x02212;72.12, 95% CI&#x0202f;=&#x0202f;(&#x02212;114.89, &#x02212;28.87)], and hesperidin [WMD&#x0202f;=&#x0202f;&#x02212;53.78, 95% CI&#x0202f;=&#x0202f;(&#x02212;105.8, &#x02212;1.89)] in lowering TG. More results with differences are presented in <xref rid="tab5" ref-type="table">Table 5</xref>. In terms of lowering serum TG, the SUCRA probability ranking results showed that naringenin (99.00%) was ranked highest, followed by quercetin (85.73%) and genistin/genistein (69.22%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab5"><label>Table 5</label><caption><p>League table of TG of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">EA</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;16.32 (&#x02212;16.94, &#x02212;15.7)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;35.05 (&#x02212;50.65, &#x02212;19.59)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;43.06 (&#x02212;84.4, &#x02212;1.69)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;37.57 (&#x02212;60.56, &#x02212;14.67)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;22.5 (&#x02212;26.99, &#x02212;17.99)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;92.5 (&#x02212;126.53, &#x02212;58.09)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;31.26 (&#x02212;40.11, &#x02212;22.42)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.93 (&#x02212;13.76, 9.77)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;19.65 (&#x02212;52.57, 13.67)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;17.57 (&#x02212;27.27, &#x02212;7.85)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;20.42 (&#x02212;46.66, 5.68)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;38.59 (&#x02212;77.84, 0.57)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;57.49 (&#x02212;87.27, &#x02212;27.45)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>16.32 (15.7, 16.94)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">EA</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;18.73 (&#x02212;34.32, &#x02212;3.25)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;26.75 (&#x02212;68.07, 14.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;21.25 (&#x02212;44.25, 1.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;6.18 (&#x02212;10.71, &#x02212;1.63)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;76.18 (&#x02212;110.18, &#x02212;41.77)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;14.93 (&#x02212;23.79, &#x02212;6.07)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>14.39 (2.55, 26.11)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.34 (&#x02212;36.27, 30)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.25 (&#x02212;10.97, 8.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.11 (&#x02212;30.37, 22.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;22.28 (&#x02212;61.51, 16.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;41.17 (&#x02212;70.97, &#x02212;11.15)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>35.05 (19.59, 50.65)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>18.73 (3.25, 34.32)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.04 (&#x02212;52.19, 36)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.5 (&#x02212;30.32, 25.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.54 (&#x02212;3.59, 28.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;57.46 (&#x02212;94.86, &#x02212;19.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.79 (&#x02212;13.98, 21.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>33.07 (13.65, 52.58)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">15.43 (&#x02212;21.06, 52.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.46 (&#x02212;0.84, 35.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.61 (&#x02212;15.89, 45.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.59 (&#x02212;45.66, 38.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;22.43 (&#x02212;56.02, 11.36)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>43.06 (1.69, 84.4)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">26.75 (&#x02212;14.67, 68.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.04 (&#x02212;36, 52.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">5.51 (&#x02212;41.91, 52.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.56 (&#x02212;21.14, 62.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;49.42 (&#x02212;103.34, 4.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.79 (&#x02212;30.56, 54.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">41.08 (&#x02212;1.86, 84.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">23.53 (&#x02212;29.36, 76.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">25.49 (&#x02212;16.92, 67.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">22.69 (&#x02212;26.42, 71.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.42 (&#x02212;52.48, 61.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.4 (&#x02212;65.44, 36.76)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>37.57 (14.67, 60.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">21.25 (&#x02212;1.68, 44.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (&#x02212;25.16, 30.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.51 (&#x02212;52.82, 41.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">15.07 (&#x02212;8.19, 38.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;54.89 (&#x02212;95.86, &#x02212;13.59)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34 (&#x02212;18.22, 30.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>35.67 (10.01, 61.34)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">17.97 (&#x02212;22.18, 58.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.02 (&#x02212;4.77, 44.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.15 (&#x02212;17.5, 51.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.02 (&#x02212;46.43, 44.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;19.84 (&#x02212;57.54, 17.91)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>22.5 (17.99, 26.99)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6.18 (1.63, 10.71)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.54 (&#x02212;28.82, 3.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;20.56 (&#x02212;62.11, 21.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.07 (&#x02212;38.43, 8.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;70 (&#x02212;104.33, &#x02212;35.33)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.74 (&#x02212;18.66, 1.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>20.56 (7.92, 33.11)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.82 (&#x02212;30.36, 36.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.94 (&#x02212;5.82, 15.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.05 (&#x02212;24.53, 28.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;16.12 (&#x02212;55.57, 23.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;34.94 (&#x02212;65.11, &#x02212;4.65)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>92.5 (58.09, 126.53)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>76.18 (41.77, 110.18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>57.46 (19.56, 94.86)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">49.42 (&#x02212;4.18, 103.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>54.89 (13.59, 95.86)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>70 (35.33, 104.33)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>61.26 (25.7, 96.53)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>90.54 (54.25, 126.58)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>72.82 (25.32, 120.49)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>74.94 (39.23, 110.26)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>72.12 (28.87, 114.89)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>53.78 (1.89, 105.8)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">35.02 (&#x02212;10.33, 80.58)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>31.26 (22.42, 40.11)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>14.93 (6.07, 23.79)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.79 (&#x02212;21.7, 13.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.79 (&#x02212;54.22, 30.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.34 (&#x02212;30.97, 18.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.74 (&#x02212;1.19, 18.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;61.26 (&#x02212;96.53, &#x02212;25.7)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>29.31 (14.56, 44.06)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11.61 (&#x02212;22.44, 46.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>13.68 (0.54, 26.8)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">10.79 (&#x02212;16.82, 38.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.37 (&#x02212;47.56, 32.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;26.24 (&#x02212;57.29, 5.11)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.93 (&#x02212;9.77, 13.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;14.39 (&#x02212;26.11, &#x02212;2.55)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;33.07 (&#x02212;52.58, &#x02212;13.65)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;41.08 (&#x02212;84.2, 1.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;35.67 (&#x02212;61.34, &#x02212;10.01)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;20.56 (&#x02212;33.11, &#x02212;7.92)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;90.54 (&#x02212;126.58, &#x02212;54.25)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;29.31 (&#x02212;44.06, &#x02212;14.56)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.75 (&#x02212;52.68, 17.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;15.64 (&#x02212;30.81, &#x02212;0.37)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.5 (&#x02212;47.03, 10.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;36.65 (&#x02212;77.57, 4.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;55.5 (&#x02212;87.62, &#x02212;23.25)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">19.65 (&#x02212;13.67, 52.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.34 (&#x02212;30, 36.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.43 (&#x02212;52.1, 21.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;23.53 (&#x02212;76.41, 29.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.97 (&#x02212;58.24, 22.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.82 (&#x02212;36.41, 30.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;72.82 (&#x02212;120.49, &#x02212;25.32)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.61 (&#x02212;46.1, 22.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.75 (&#x02212;17.65, 52.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">2.04 (&#x02212;32.58, 36.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.77 (&#x02212;43.23, 41.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;19 (&#x02212;70.18, 32.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;37.85 (&#x02212;82.31, 6.87)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>17.57 (7.85, 27.27)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.25 (&#x02212;8.46, 10.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.46 (&#x02212;35.86, 0.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;25.49 (&#x02212;67.92, 16.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;20.02 (&#x02212;44.87, 4.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.94 (&#x02212;15.64, 5.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;74.94 (&#x02212;110.26, &#x02212;39.23)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;13.68 (&#x02212;26.8, &#x02212;0.54)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>15.64 (0.37, 30.81)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.04 (&#x02212;36.49, 32.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.87 (&#x02212;30.73, 25.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;21.01 (&#x02212;61.41, 19.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;39.89 (&#x02212;71.18, &#x02212;8.4)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">20.42 (&#x02212;5.68, 46.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.11 (&#x02212;22.01, 30.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.61 (&#x02212;45.04, 15.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;22.69 (&#x02212;71.48, 26.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.15 (&#x02212;51.9, 17.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.05 (&#x02212;28.56, 24.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;72.12 (&#x02212;114.89, &#x02212;28.87)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.79 (&#x02212;38.46, 16.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.5 (&#x02212;10.16, 47.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77 (&#x02212;41.39, 43.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.87 (&#x02212;25.05, 30.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.2 (&#x02212;65.36, 29.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;36.95 (&#x02212;76.51, 2.81)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">38.59 (&#x02212;0.57, 77.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">22.28 (&#x02212;16.91, 61.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.59 (&#x02212;38.67, 45.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.42 (&#x02212;61.47, 52.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02 (&#x02212;44.49, 46.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">16.12 (&#x02212;23.28, 55.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;53.78 (&#x02212;105.8, &#x02212;1.89)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.37 (&#x02212;32.73, 47.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.65 (&#x02212;4.34, 77.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (&#x02212;32.3, 70.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">21.01 (&#x02212;19.35, 61.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.2 (&#x02212;29.19, 65.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.83 (&#x02212;68.08, 30.64)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>57.49 (27.45, 87.27)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>41.17 (11.15, 70.97)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">22.43 (&#x02212;11.36, 56.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.4 (&#x02212;36.76, 65.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">19.84 (&#x02212;17.91, 57.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>34.94 (4.65, 65.11)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;35.02 (&#x02212;80.58, 10.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">26.24 (&#x02212;5.11, 57.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>55.5 (23.25, 87.62)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">37.85 (&#x02212;6.87, 82.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>39.89 (8.4, 71.18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">36.95 (&#x02212;2.81, 76.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.83 (&#x02212;30.64, 68.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap><p>Catechin was more effective in increasing HDL-C than placebo [WMD&#x0202f;=&#x0202f;&#x02212;7.88, 95% CI&#x0202f;=&#x0202f;(&#x02212;13.03, &#x02212;2.48)], curcumin [WMD&#x0202f;=&#x0202f;&#x02212;6.62, 95% CI&#x0202f;=&#x0202f;(&#x02212;12.26, &#x02212;0.82)], DHM [WMD&#x0202f;=&#x0202f;11.36, 95% CI&#x0202f;=&#x0202f;(2.13, 20.36)], and silymarin [WMD&#x0202f;=&#x0202f;6.93, 95% CI&#x0202f;=&#x0202f;(0.48, 13.09)]. Additional results with differences are presented in <xref rid="tab6" ref-type="table">Table 6</xref>. According to the SUCRA probability ranking for increasing serum HDL-C, catechin (93.72%) was ranked highest, followed by EA (82.69%) and naringenin (63.05%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab6"><label>Table 6</label><caption><p>League table of HDL-C of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">EA</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5.29 (0.69, 9.92)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.22 (&#x02212;3.67, 6.33)</td><td align="center" valign="top" rowspan="1" colspan="1">0.64 (&#x02212;7.06, 8.38)</td><td align="center" valign="top" rowspan="1" colspan="1">1.85 (&#x02212;4.1, 7.81)</td><td align="center" valign="top" rowspan="1" colspan="1">1.26 (&#x02212;1.03, 3.43)</td><td align="center" valign="top" rowspan="1" colspan="1">3.08 (&#x02212;3.85, 10.03)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7.88 (2.48, 13.03)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.13 (&#x02212;3.38, 5.69)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.47 (&#x02212;10.97, 3.99)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (&#x02212;2.54, 4.46)</td><td align="center" valign="top" rowspan="1" colspan="1">1.24 (&#x02212;5.7, 8.23)</td><td align="center" valign="top" rowspan="1" colspan="1">0.55 (&#x02212;8, 9.1)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (&#x02212;6.46, 8.53)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;5.29 (&#x02212;9.92, &#x02212;0.69)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">EA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.08 (&#x02212;10.77, 2.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.65 (&#x02212;13.62, 4.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.46 (&#x02212;10.95, 4.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.03 (&#x02212;9.23, 1.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.2 (&#x02212;10.54, 6.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.6 (&#x02212;4.54, 9.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.16 (&#x02212;10.59, 2.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;8.77 (&#x02212;17.57, &#x02212;0.02)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.33 (&#x02212;10.13, 1.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.06 (&#x02212;12.4, 4.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.74 (&#x02212;14.46, 4.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.27 (&#x02212;13.04, 4.53)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.22 (&#x02212;6.33, 3.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.08 (&#x02212;2.85, 10.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.58 (&#x02212;9.87, 8.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;7.24, 8.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04 (&#x02212;5.61, 5.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.86 (&#x02212;6.77, 10.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.65 (&#x02212;0.81, 13.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.09 (&#x02212;6.89, 6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.7 (&#x02212;13.8, 4.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.26 (&#x02212;6.49, 5.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 (&#x02212;8.7, 8.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.67 (&#x02212;10.63, 9.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.18 (&#x02212;9.3, 8.72)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.64 (&#x02212;8.38, 7.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.65 (&#x02212;4.35, 13.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58 (&#x02212;8.53, 9.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">1.21 (&#x02212;8.64, 10.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.62 (&#x02212;7.5, 8.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.43 (&#x02212;7.92, 12.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.23 (&#x02212;2.23, 16.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49 (&#x02212;8.41, 9.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.13 (&#x02212;14.91, 6.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32 (&#x02212;8.17, 8.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;9.8, 11.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.09 (&#x02212;11.6, 11.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39 (&#x02212;10.41, 11.15)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.85 (&#x02212;7.81, 4.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.46 (&#x02212;4.07, 10.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;8.32, 7.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.21 (&#x02212;10.99, 8.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.59 (&#x02212;6.99, 5.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (&#x02212;7.93, 10.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.04 (&#x02212;2.04, 13.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.71 (&#x02212;8.19, 6.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.32 (&#x02212;14.87, 4.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.87 (&#x02212;7.83, 6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.58 (&#x02212;9.81, 8.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.28 (&#x02212;11.72, 9.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.82 (&#x02212;10.37, 8.76)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.26 (&#x02212;3.43, 1.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.03 (&#x02212;1.01, 9.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.04 (&#x02212;5.36, 5.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.62 (&#x02212;8.58, 7.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59 (&#x02212;5.68, 6.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">1.81 (&#x02212;5.36, 9.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6.62 (0.82, 12.26)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.12 (&#x02212;5.12, 5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.72 (&#x02212;12.49, 3.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.3 (&#x02212;4.39, 3.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;7.26, 7.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.7 (&#x02212;9.49, 8.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22 (&#x02212;7.98, 7.66)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;3.08 (&#x02212;10.03, 3.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2 (&#x02212;6.11, 10.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.86 (&#x02212;10.27, 6.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.43 (&#x02212;12.8, 7.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.24 (&#x02212;10.36, 7.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.81 (&#x02212;9.19, 5.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8 (&#x02212;4.05, 13.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.94 (&#x02212;10.17, 6.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.55 (&#x02212;16.73, 3.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.14 (&#x02212;9.88, 5.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.86 (&#x02212;11.68, 8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.52 (&#x02212;13.51, 8.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.05 (&#x02212;12.25, 8.17)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;7.88 (&#x02212;13.03, &#x02212;2.48)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.6 (&#x02212;9.44, 4.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.65 (&#x02212;13.73, 0.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.23 (&#x02212;16.45, 2.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.04 (&#x02212;13.86, 2.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;6.62 (&#x02212;12.26, &#x02212;0.82)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.8 (&#x02212;13.37, 4.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.74 (&#x02212;13.57, 0.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;11.36 (&#x02212;20.36, &#x02212;2.13)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;6.93 (&#x02212;13.09, &#x02212;0.48)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.63 (&#x02212;15.25, 2.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.32 (&#x02212;17.24, 2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.83 (&#x02212;15.9, 2.38)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.13 (&#x02212;5.69, 3.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.16 (&#x02212;2.34, 10.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09 (&#x02212;6.6, 6.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.49 (&#x02212;9.43, 8.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.71 (&#x02212;6.81, 8.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12 (&#x02212;5, 5.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.94 (&#x02212;6.32, 10.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.74 (&#x02212;0.3, 13.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.62 (&#x02212;13.35, 4.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.18 (&#x02212;5.93, 5.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 (&#x02212;8.18, 8.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.59 (&#x02212;10.29, 9.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1 (&#x02212;8.88, 8.61)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3.47 (&#x02212;3.99, 10.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>8.77 (0.02, 17.57)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.7 (&#x02212;4.2, 13.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.13 (&#x02212;6.62, 14.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.32 (&#x02212;4.26, 14.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.72 (&#x02212;3.12, 12.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.55 (&#x02212;3.6, 16.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>11.36 (2.13, 20.36)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.62 (&#x02212;4.1, 13.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">4.42 (&#x02212;3.8, 12.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.73 (&#x02212;5.54, 14.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.03 (&#x02212;7.26, 15.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.49 (&#x02212;6.04, 15.05)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.96 (&#x02212;4.46, 2.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 (&#x02212;1.48, 10.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.26 (&#x02212;5.73, 6.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.32 (&#x02212;8.79, 8.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87 (&#x02212;6, 7.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 (&#x02212;3.91, 4.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.14 (&#x02212;5.65, 9.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6.93 (0.48, 13.09)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18 (&#x02212;5.54, 5.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.42 (&#x02212;12.72, 3.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28 (&#x02212;7.5, 8.13)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.42 (&#x02212;9.67, 8.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07 (&#x02212;8.22, 8.36)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.24 (&#x02212;8.23, 5.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.06 (&#x02212;4.34, 12.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;8.49, 8.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;11.02, 9.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58 (&#x02212;8.56, 9.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 (&#x02212;7.37, 7.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.86 (&#x02212;8, 11.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.63 (&#x02212;2.25, 15.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1 (&#x02212;8.42, 8.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.73 (&#x02212;14.99, 5.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.28 (&#x02212;8.13, 7.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.69 (&#x02212;11.71, 10.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22 (&#x02212;10.44, 10.03)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;0.55 (&#x02212;9.1, 8)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.74 (&#x02212;4.97, 14.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67 (&#x02212;9.14, 10.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09 (&#x02212;11.43, 11.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28 (&#x02212;9.08, 11.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 (&#x02212;8.16, 9.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.52 (&#x02212;8.39, 13.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.32 (&#x02212;2.8, 17.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59 (&#x02212;9.07, 10.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.03 (&#x02212;15.38, 7.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42 (&#x02212;8.84, 9.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69 (&#x02212;10.32, 11.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48 (&#x02212;10.93, 11.81)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.03 (&#x02212;8.53, 6.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.27 (&#x02212;4.53, 13.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18 (&#x02212;8.72, 9.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.39 (&#x02212;11.15, 10.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.82 (&#x02212;8.76, 10.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 (&#x02212;7.66, 7.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.05 (&#x02212;8.17, 12.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.83 (&#x02212;2.38, 15.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 (&#x02212;8.61, 8.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.49 (&#x02212;15.05, 6.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.07 (&#x02212;8.36, 8.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 (&#x02212;10.03, 10.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.48 (&#x02212;11.81, 10.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap><p>No statistical differences were noted in the impact of these dietary polyphenols on LDL-C levels (<xref rid="tab7" ref-type="table">Table 7</xref>). The SUCRA probability ranking results for lowering serum LDL-C levels indicated that DHM (73.22%) was more effective than GA and CA (71.95%), followed by naringenin (66.44%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab7"><label>Table 7</label><caption><p>League table of LDL-C of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">EA</td><td align="center" valign="top" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="top" rowspan="1" colspan="1">Catechin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="top" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8.83 (&#x02212;29.38, 11.67)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;9.16 (&#x02212;27.72, 9.71)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.49 (&#x02212;30.82, 30.06)</td><td align="center" valign="top" rowspan="1" colspan="1">1.61 (&#x02212;20.86, 24.08)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8.47 (&#x02212;17.52, 0.78)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;16.02 (&#x02212;46.07, 14.03)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;10.84 (&#x02212;31.95, 10.85)</td><td align="center" valign="top" rowspan="1" colspan="1">4.58 (&#x02212;10.56, 20.06)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;19.77 (&#x02212;50.14, 10.68)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.34 (&#x02212;23.52, 8.69)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;19.13 (&#x02212;50.24, 11.87)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;13.1 (&#x02212;45.41, 19.16)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;13.65 (&#x02212;43.27, 15.86)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">8.83 (&#x02212;11.67, 29.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">EA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.37 (&#x02212;27.88, 27.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.39 (&#x02212;28.39, 45.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.49 (&#x02212;20.06, 40.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33 (&#x02212;22, 22.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.19 (&#x02212;43.83, 29.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2 (&#x02212;31.54, 27.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.36 (&#x02212;12.01, 39.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.92 (&#x02212;47.89, 25.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.47 (&#x02212;24.44, 27.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.31 (&#x02212;47.42, 27.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.25 (&#x02212;42.39, 33.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.81 (&#x02212;40.86, 30.92)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">9.16 (&#x02212;9.71, 27.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37 (&#x02212;27.58, 27.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthocyanin</td><td align="center" valign="middle" rowspan="1" colspan="1">8.69 (&#x02212;27.14, 44.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.87 (&#x02212;18.69, 39.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69 (&#x02212;20.2, 21.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.87 (&#x02212;42.3, 28.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.68 (&#x02212;30.19, 26.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.74 (&#x02212;10.28, 38.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.59 (&#x02212;46.38, 24.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8 (&#x02212;23.02, 26.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.01 (&#x02212;46.32, 26.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.89 (&#x02212;41.38, 33.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.52 (&#x02212;39.63, 30.46)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.49 (&#x02212;30.06, 30.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.39 (&#x02212;45.06, 28.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.69 (&#x02212;44.28, 27.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">2.12 (&#x02212;35.79, 39.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.97 (&#x02212;39.74, 23.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.59 (&#x02212;58.43, 27.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.31 (&#x02212;47.39, 26.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.06 (&#x02212;28.84, 39.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;19.27 (&#x02212;62.58, 23.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.86 (&#x02212;41.57, 27.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.67 (&#x02212;62.11, 24.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.55 (&#x02212;57.12, 31.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.23 (&#x02212;55.7, 29.28)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;1.61 (&#x02212;24.08, 20.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.49 (&#x02212;40.83, 20.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.87 (&#x02212;39.9, 18.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;39.95, 35.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.14 (&#x02212;34.22, 14.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.66 (&#x02212;55.28, 20)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.49 (&#x02212;43.33, 18.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.92 (&#x02212;24.02, 30.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;21.38 (&#x02212;59.14, 16.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.99 (&#x02212;36.63, 18.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;20.78 (&#x02212;59.06, 17.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;14.64 (&#x02212;54.16, 24.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.35 (&#x02212;52.6, 21.89)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">8.47 (&#x02212;0.78, 17.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.33 (&#x02212;22.92, 22)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.69 (&#x02212;21.44, 20.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.97 (&#x02212;23.85, 39.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.14 (&#x02212;14.31, 34.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.58 (&#x02212;39.07, 23.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.37 (&#x02212;25.58, 20.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.05 (&#x02212;4.64, 30.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.29 (&#x02212;43.27, 20.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.11 (&#x02212;17.61, 19.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.69 (&#x02212;43.09, 21.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.6 (&#x02212;38.31, 28.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.17 (&#x02212;36.38, 25.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">16.02 (&#x02212;14.03, 46.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.19 (&#x02212;29.15, 43.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.87 (&#x02212;28.5, 42.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.59 (&#x02212;27.32, 58.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.66 (&#x02212;20, 55.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.58 (&#x02212;23.73, 39.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" rowspan="1" colspan="1">5.15 (&#x02212;31.48, 42.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.57 (&#x02212;13.03, 54.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.72 (&#x02212;46.45, 39.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.68 (&#x02212;25.41, 42.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.13 (&#x02212;46.23, 40.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (&#x02212;41.14, 47.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.37 (&#x02212;39.96, 44.54)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">10.84 (&#x02212;10.85, 31.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (&#x02212;27.82, 31.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.68 (&#x02212;26.79, 30.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.31 (&#x02212;26.98, 47.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.49 (&#x02212;18.71, 43.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.37 (&#x02212;20.98, 25.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.15 (&#x02212;42.4, 31.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">15.41 (&#x02212;10.87, 41.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.94 (&#x02212;46.45, 27.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.46 (&#x02212;23.31, 30.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.32 (&#x02212;45.95, 29.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.29 (&#x02212;41.05, 36.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.86 (&#x02212;39.54, 33.56)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;4.58 (&#x02212;20.06, 10.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.36 (&#x02212;39.27, 12.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.74 (&#x02212;38.03, 10.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.06 (&#x02212;39.29, 28.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.92 (&#x02212;30.41, 24.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.05 (&#x02212;30.82, 4.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;20.57 (&#x02212;54.53, 13.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.41 (&#x02212;41.79, 10.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;24.3 (&#x02212;58.66, 9.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.92 (&#x02212;34.29, 9.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;23.68 (&#x02212;58.38, 10.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;17.67 (&#x02212;53.44, 17.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;18.21 (&#x02212;51.83, 14.87)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">19.77 (&#x02212;10.68, 50.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.92 (&#x02212;25.83, 47.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.59 (&#x02212;24.98, 46.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">19.27 (&#x02212;23.69, 62.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">21.38 (&#x02212;16.48, 59.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.29 (&#x02212;20.43, 43.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.72 (&#x02212;39.01, 46.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.94 (&#x02212;27.89, 46.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.3 (&#x02212;9.47, 58.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">12.37 (&#x02212;22, 46.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58 (&#x02212;42.53, 44.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.65 (&#x02212;37.49, 50.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (&#x02212;36.37, 48.74)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7.34 (&#x02212;8.69, 23.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.47 (&#x02212;27.56, 24.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.8 (&#x02212;26.48, 23.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.86 (&#x02212;27.48, 41.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.99 (&#x02212;18.62, 36.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.11 (&#x02212;19.53, 17.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.68 (&#x02212;42.68, 25.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.46 (&#x02212;30.14, 23.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.92 (&#x02212;9.93, 34.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;12.37 (&#x02212;46.82, 22)</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.73 (&#x02212;46.7, 23.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.7 (&#x02212;41.93, 30.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.33 (&#x02212;39.92, 27.16)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">19.13 (&#x02212;11.87, 50.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.31 (&#x02212;27.05, 47.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.01 (&#x02212;26.11, 46.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.67 (&#x02212;24.69, 62.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.78 (&#x02212;17.67, 59.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.69 (&#x02212;21.55, 43.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.13 (&#x02212;40.09, 46.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.32 (&#x02212;29.2, 45.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">23.68 (&#x02212;10.82, 58.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.58 (&#x02212;44.54, 42.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.73 (&#x02212;23.14, 46.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">GA and CA</td><td align="center" valign="middle" rowspan="1" colspan="1">6.04 (&#x02212;38.59, 50.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.47 (&#x02212;37.33, 48.45)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">13.1 (&#x02212;19.16, 45.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.25 (&#x02212;33.9, 42.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.89 (&#x02212;33.26, 41.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.55 (&#x02212;31.62, 57.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.64 (&#x02212;24.54, 54.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6 (&#x02212;28.8, 38.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3 (&#x02212;47.07, 41.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.29 (&#x02212;36.21, 41.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.67 (&#x02212;17.89, 53.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.65 (&#x02212;50.92, 37.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.7 (&#x02212;30.25, 41.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.04 (&#x02212;50.8, 38.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61 (&#x02212;44.36, 43.15)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">13.65 (&#x02212;15.86, 43.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.81 (&#x02212;30.92, 40.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.52 (&#x02212;30.46, 39.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.23 (&#x02212;29.28, 55.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.35 (&#x02212;21.89, 52.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.17 (&#x02212;25.6, 36.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.37 (&#x02212;44.54, 39.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.86 (&#x02212;33.56, 39.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.21 (&#x02212;14.87, 51.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6 (&#x02212;48.74, 36.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.33 (&#x02212;27.16, 39.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.47 (&#x02212;48.45, 37.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 (&#x02212;43.15, 44.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</p></table-wrap-foot></table-wrap></sec><sec id="sec23"><label>3.3.6</label><title>Inflammation-related outcome measures</title><p>Twelve studies reported serum TNF-&#x003b1; levels after dietary polyphenol treatment for NAFLD.</p><p>The NMA results demonstrated that quercetin was superior to placebo [WMD&#x0202f;=&#x0202f;51.61, 95% CI&#x0202f;=&#x0202f;(22.27, 80.77)], genistin/genistein [WMD&#x0202f;=&#x0202f;34.71, 95% CI&#x0202f;=&#x0202f;(0.55, 68.49)], CA [WMD&#x0202f;=&#x0202f;50, 95% CI&#x0202f;=&#x0202f;(17.96, 82.03)], curcumin [WMD&#x0202f;=&#x0202f;46.59, 95% CI&#x0202f;=&#x0202f;(15.99, 76.87)], resveratrol [WMD&#x0202f;=&#x0202f;50.07, 95% CI&#x0202f;=&#x0202f;(19.81, 79.9)], DHM [WMD&#x0202f;=&#x0202f;50.29, 95% CI&#x0202f;=&#x0202f;(18.39, 82.18)], and hesperidin [WMD&#x0202f;=&#x0202f;45.29, 95% CI&#x0202f;=&#x0202f;(13.02, 77.39)] in reducing TNF-&#x003b1; (<xref rid="tab8" ref-type="table">Table 8</xref>). According to the SUCRA probability ranking for lowering serum TNF-&#x003b1; levels, quercetin (99.47%) was ranked highest, followed by genistin/genistein (79.74%) and hesperidin (55.45%) (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab8"><label>Table 8</label><caption><p>League table of TNF-&#x003b1; of different dietary polyphenols.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="top" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="top" rowspan="1" colspan="1">DHM</td><td align="center" valign="top" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="top" rowspan="1" colspan="1">Quercetin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;16.91 (&#x02212;34.14, 0.22)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.58 (&#x02212;14.87, 11.92)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.92 (&#x02212;13.93, 3.27)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.46 (&#x02212;8.75, 4.92)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.32 (&#x02212;14.38, 11.9)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;6.33 (&#x02212;19.97, 7.37)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x02212;51.61 (&#x02212;80.77, &#x02212;22.27)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">16.91 (&#x02212;0.22, 34.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistin/Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">15.36 (&#x02212;6.22, 37.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">11.97 (&#x02212;7.42, 30.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.38 (&#x02212;3.36, 33.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.59 (&#x02212;5.81, 37.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.58 (&#x02212;11.21, 32.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;34.71 (&#x02212;68.49, &#x02212;0.55)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.58 (&#x02212;11.92, 14.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.36 (&#x02212;37.19, 6.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.36 (&#x02212;19.71, 11.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11 (&#x02212;15.5, 14.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 (&#x02212;18.54, 19.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.77 (&#x02212;23.91, 14.41)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;50 (&#x02212;82.03, &#x02212;17.96)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.92 (&#x02212;3.27, 13.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;11.97 (&#x02212;30.79, 7.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.36 (&#x02212;11.97, 19.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">3.48 (&#x02212;7.52, 14.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.58 (&#x02212;11.64, 19.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.4 (&#x02212;17.1, 15.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;46.59 (&#x02212;76.87, &#x02212;15.99)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.46 (&#x02212;4.92, 8.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.38 (&#x02212;33.65, 3.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.11 (&#x02212;14.62, 15.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.48 (&#x02212;14.36, 7.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13 (&#x02212;14.24, 15.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.86 (&#x02212;19.75, 10.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;50.07 (&#x02212;79.9, &#x02212;19.81)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.32 (&#x02212;11.9, 14.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;15.59 (&#x02212;37.3, 5.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25 (&#x02212;19.04, 18.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.58 (&#x02212;19.85, 11.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13 (&#x02212;15.47, 14.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">DHM</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.04 (&#x02212;24.01, 13.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;50.29 (&#x02212;82.18, &#x02212;18.39)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">6.33 (&#x02212;7.37, 19.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.58 (&#x02212;32.49, 11.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.77 (&#x02212;14.41, 23.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4 (&#x02212;15.1, 17.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.86 (&#x02212;10.96, 19.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.04 (&#x02212;13.98, 24.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">Hesperidin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x02212;45.29 (&#x02212;77.39, &#x02212;13.02)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>51.61 (22.27, 80.77)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>34.71 (0.55, 68.49)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>50 (17.96, 82.03)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>46.59 (15.99, 76.87)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>50.07 (19.81, 79.9)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>50.29 (18.39, 82.18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>45.29 (13.02, 77.39)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><p>
<sup>#Bold font represents a statistical difference. The blue module represents different dietary polyphenols. The green module represents row-column comparisons of intervention effects of different dietary polyphenols. The orange module represents column-row comparisons of intervention effects of different dietary polyphenols.</sup>
</p></table-wrap-foot></table-wrap></sec></sec><sec id="sec24"><label>3.4</label><title>Publication bias</title><p>A corrected comparison funnel plot was created for each outcome measure to appraise publication bias. Upon visual inspection of the funnel plot, no notable publication bias was detected (<xref rid="fig5" ref-type="fig">Figure 5</xref>). Funnel plots for publication bias of the other measures are provided in <xref rid="SM3" ref-type="supplementary-material">Supplementary material 3</xref>.</p><fig position="float" id="fig5"><label>Figure 5</label><caption><p>Funnel plot of different outcome indicators of NAFLD patients treated with different dietary polyphenol supplements. <bold>(A)</bold> BMI; <bold>(B)</bold> ALT; <bold>(C)</bold> AST; <bold>(D)</bold> TC; <bold>(E)</bold> TG; <bold>(F)</bold> HDL-C; <bold>(G)</bold> LDL-C; <bold>(H)</bold> TNF-&#x003b1;.</p></caption><graphic xlink:href="fnut-12-1582861-g005" position="float"/></fig></sec></sec><sec sec-type="discussion" id="sec25"><label>4</label><title>Discussion</title><p>The effects of 13 various single (or combined) dietary polyphenol supplements on NAFLD treatment are compared in this study. The results indicate that naringenin is the most effective polyphenol for lowering serum TC and TG, catechin for reducing BMI and ALT, AST, ALP (98.65%) and raising HDL-C, DHM for reducing LDL-C, FBG (82.80%), and insulin levels (77.34%) and quercetin for lowering TNF-&#x003b1;. In conclusion, our findings suggest that catechin may be the most appropriate dietary polyphenol supplement for treating patients with NAFLD.</p><p>Catechin is a naturally occurring polyphenolic compound found in dried tea leaves and is the main bioactive ingredient in green tea extracts. The results of this study imply that catechin is the most effective in reducing BMI, consistent with previous studies (<xref rid="ref14" ref-type="bibr">14</xref>, <xref rid="ref77" ref-type="bibr">77</xref>). BMI is a common measure of overweight/obesity, and individuals with these conditions are more likely to develop NAFLD (<xref rid="ref78" ref-type="bibr">78</xref>). Epigallocatechin gallate (EGCG) is the most abundant (60.89%) effective catechin in green tea (<xref rid="ref79" ref-type="bibr">79</xref>). Animal studies (<xref rid="ref80" ref-type="bibr">80</xref>, <xref rid="ref81" ref-type="bibr">81</xref>) indicate that EGCG reduces body weight by (i) decreasing intestinal absorption of lipids and proteins, reducing caloric intake, and (ii) activating adenosine monophosphate-activated protein kinase (AMPK), which regulates lipid, cholesterol, and glucose metabolism in the liver, skeletal muscles, and white adipose tissue, thereby promoting lipid and glucose catabolism (<xref rid="ref82" ref-type="bibr">82</xref>).</p><p>Besides reducing BMI, catechin can regulate serum lipids in NAFLD patients by lowering TC levels and raising HDL-C levels. The liver is the primary organ responsible for regulating lipid metabolism. High TC levels are positively tied to NAFLD onset (<xref rid="ref83" ref-type="bibr">83</xref>), while low HDL-C levels are a risk factor for both NAFLD and severe liver diseases (<xref rid="ref83" ref-type="bibr">83</xref>, <xref rid="ref84" ref-type="bibr">84</xref>). Moreover, the TC/HDL-C ratio serves as a more reliable predictor of NAFLD. A higher ratio indicates a greater risk of BMI-related NAFLD (<xref rid="ref83" ref-type="bibr">83</xref>, <xref rid="ref85" ref-type="bibr">85</xref>). Catechin can increase HDL-C levels in overweight/obese individuals (<xref rid="ref86" ref-type="bibr">86</xref>). In addition, the consumption of green tea drinks or extracts can notably reduce serum TC levels in adults (<xref rid="ref87" ref-type="bibr">87</xref>), demonstrating the role of catechins in lipid metabolism regulation. An animal experiment suggests that EGCG can inhibit hepatic cholesterol synthesis by modulating the sterol regulatory element-binding protein 2/silent information regulator 1 (SIRT1)/forkhead box transcription factor O1 signaling pathway, thereby affecting lipid metabolism in hyperlipidemic rats (<xref rid="ref88" ref-type="bibr">88</xref>). Moreover, oxidative stress is a core mechanism in the progression of NAFLD. Nuclear factor erythroid 2-related factor 2 (NRF2) is a key factor that limits oxidative stress through its transcriptional activity and can regulate the expression of lipid metabolism-related genes, while EGCG can notably inhibit oxidative stress via the NRF2 signaling pathway (<xref rid="ref89" ref-type="bibr">89</xref>).</p><p>ALT, AST, and ALP serve as traditional blood biomarkers for evaluating liver cell damage. Elevated levels of AST and ALT indicate hepatocellular necrosis, while elevated ALP levels suggest damage to biliary epithelial cells or tubular membranes (<xref rid="ref90" ref-type="bibr">90</xref>). All three may be linked to the risk of HCC development (<xref rid="ref91" ref-type="bibr">91</xref>). Multiple animal studies have confirmed that EGCG intervention can reduce serum liver enzyme levels in NAFLD/NASH model animals. The action mechanism is multifaceted, including the improvement of insulin sensitivity, facilitation of glucose metabolism in liver tissue, and regulation of the expression of inflammatory mediators and related pathological changes (<xref rid="ref89" ref-type="bibr">89</xref>, <xref rid="ref92" ref-type="bibr">92</xref>, <xref rid="ref93" ref-type="bibr">93</xref>). Moreover, catechin is a natural iron chelator that can restrict iron absorption, potentially helping to prevent liver iron accumulation and slow the progression of NASH (<xref rid="ref59" ref-type="bibr">59</xref>, <xref rid="ref62" ref-type="bibr">62</xref>, <xref rid="ref94" ref-type="bibr">94</xref>).</p><p>This study includes four RCTs on catechin treatment for NAFLD. One study notes mild bloating in NAFLD patients who take green tea extract. However, it does not specify whether this is linked to the green tea extract (<xref rid="ref61" ref-type="bibr">61</xref>). Another article states that taking a high dose of catechin (1,080&#x0202f;mg/700&#x0202f;mL) does not induce any side effects (<xref rid="ref59" ref-type="bibr">59</xref>). Although high-dose catechin may offer more benefits in reducing patients&#x02019; weight, BMI, and ALT (<xref rid="ref59" ref-type="bibr">59</xref>, <xref rid="ref95" ref-type="bibr">95</xref>), it may also lead to mild nausea and stomach pain, particularly when taken on an empty stomach (<xref rid="ref89" ref-type="bibr">89</xref>). Basic research also reveals that high doses of EGCG can result in mild liver damage in mice (<xref rid="ref96" ref-type="bibr">96</xref>) and concentration-dependent hepatocyte death (<xref rid="ref97" ref-type="bibr">97</xref>). Hence, the safety dosage of catechin still requires further research to be determined. Furthermore, the bioavailability of catechins is influenced by various processes, such as chemical degradation, microbial metabolism, and hepatic metabolism. Consequently, only a small fraction of the catechins that enter the intestine after tea consumption are absorbed (<xref rid="ref98" ref-type="bibr">98</xref>). This issue warrants further attention.</p><p>High levels of TC and TG are connected to the development of NAFLD (<xref rid="ref83" ref-type="bibr">83</xref>, <xref rid="ref84" ref-type="bibr">84</xref>). Naringenin is a natural citrus flavonoid that is widely present in grapefruit and oranges. It is the most effective dietary polyphenol in this study for decreasing serum TC and TG, aligning with prior research results (<xref rid="ref77" ref-type="bibr">77</xref>). According to basic research results, the mechanisms through which naringenin reduces TC and TG levels in NAFLD/NASH rodent models are outlined below: (i) The key regulatory enzyme that inhibits cholesterol synthesis, 3-hydroxy-3-methylglutaryl-coenzyme A reductase is involved in lipid metabolism (<xref rid="ref99" ref-type="bibr">99</xref>). (ii) By inhibiting the activation of the NLR family pyrin domain containing 3 inflammasome in hepatocytes, inflammation and lipid accumulation are alleviated (<xref rid="ref100" ref-type="bibr">100</xref>). (iii) By activating the SIRT1-mediated signaling cascade, naringenin regulates the expression of lipid metabolism-related genes (fatty acid synthase, stearoyl-CoA desaturase 1, peroxisome proliferator-activated receptor &#x003b1;, carnitine palmitoyltransferase 1&#x003b1;) and clears reactive oxygen species and lipid peroxides in the body (<xref rid="ref101" ref-type="bibr">101</xref>). (iv) By downregulating the liver X receptor in the liver and activating AMPK, naringenin stimulates fatty acid oxidation and inhibits lipogenesis (<xref rid="ref102" ref-type="bibr">102</xref>). Additionally, since gut bacteria can influence host lipid metabolism, naringenin can lower TC and TG levels in NASH mice by regulating the gut microbiota (<xref rid="ref103" ref-type="bibr">103</xref>). Two included RCTs on naringenin for NAFLD show no side effects (<xref rid="ref71" ref-type="bibr">71</xref>, <xref rid="ref72" ref-type="bibr">72</xref>). An animal study indicates that different concentrations of naringenin (1&#x0202f;mM, 10&#x0202f;mM, 100&#x0202f;mM) do not cause intestinal damage in rats (<xref rid="ref104" ref-type="bibr">104</xref>). However, there are contradictory research results (<xref rid="ref105" ref-type="bibr">105</xref>). Consequently, the safety of naringenin must be explored in more detail. Moreover, although naringenin can be rapidly absorbed after oral administration, its bioavailability is only 15%. This low bioavailability is attributed to its very low affinity for water and the prolonged metabolic time during intestinal passage (<xref rid="ref106" ref-type="bibr">106</xref>, <xref rid="ref107" ref-type="bibr">107</xref>).</p><p>DHM is the primary flavonoid substance in the edible medicinal plant <italic>Ampelopsis grossedentata</italic>. In this study, it is the most effective dietary polyphenol in reducing serum LDL-C, FBG, and insulin levels. High serum levels of LDL-C are the primary cause of the development of atherosclerosis (<xref rid="ref108" ref-type="bibr">108</xref>). NAFLD is prevalent in T2DM patients (<xref rid="ref109" ref-type="bibr">109</xref>). Chen et al. (<xref rid="ref73" ref-type="bibr">73</xref>) propose that DHM lowers LDL-C, FBG, and insulin by regulating fibroblast growth factor 21 (FGF21) to improve IR. FGF21 is expressed in the liver, adipose tissue, and pancreas, playing a key role in the regulation of glucose and lipid metabolism. It may potentially develop into a biomarker for monitoring NAFLD/NASH (<xref rid="ref73" ref-type="bibr">73</xref>, <xref rid="ref110" ref-type="bibr">110</xref>). Basic research indicates that DHM is a potential agonist of peroxisome proliferator-activated receptor &#x003b3; (PPAR&#x003b3;) (<xref rid="ref112" ref-type="bibr">112</xref>), an important metabolic regulatory factor for targeted treatment of NAFLD (<xref rid="ref111" ref-type="bibr">111</xref>). DHM improves IR by activating PPAR&#x003b3; and subsequently modulating the FGF21-AMPK pathway (<xref rid="ref112" ref-type="bibr">112</xref>). No toxicity has been reported for DHM within the typical dosage range. The only included RCT on DHM treatment for NAFLD shows that participants taking 600mg of DHM capsules daily experience no adverse effects (<xref rid="ref73" ref-type="bibr">73</xref>). A study demonstrates that mice with NAFLD receive oral doses of DHM at 500 mg/kg/day, 750 mg/kg/day, and 1000 mg/kg/day for 8 weeks, with no adverse reactions reported (<xref rid="ref113" ref-type="bibr">113</xref>). Moreover, an acute toxicity test on DHM reveals that its toxicity is very slight, the highest tolerance level for oral gavage in rats is 5g/kg body weight (<xref rid="ref114" ref-type="bibr">114</xref>). The maximum safe dose for mice is around 16 g/kg, while for adults, it is approximately 1.6 g/kg, based on the body surface area standardization method (<xref rid="ref115" ref-type="bibr">115</xref>). This could serve as a reference for determining the safe dosage of DHM. The absolute bioavailability of DHM in rats is less than 10%, which may be due to its poor solubility in water, as well as its metabolism and elimination within the intestinal tract (<xref rid="ref116" ref-type="bibr">116</xref>).</p><p>Quercetin, a natural flavonoid found abundantly in various foods (like apples, onions, and tomatoes), possesses potent anti-inflammatory capabilities. It has the greatest effect in reducing TNF-&#x003b1; in NAFLD patients. Inflammation is regarded as a critical driver of NAFLD progression and can promote hepatic steatosis (<xref rid="ref100" ref-type="bibr">100</xref>). Furthermore, TNF-&#x003b1; can mediate inflammation by activating mitogen-activated protein kinases (MAPK) signaling pathways, like extracellular signal-regulated kinase, c-Jun N-terminal kinase, nuclear factor kappa-B (NF-&#x003ba;B), and activator protein 1 (AP-1) (<xref rid="ref75" ref-type="bibr">75</xref>). Nevertheless, quercetin can block the TNF-&#x003b1;-induced inflammatory cascade by inhibiting MAPK or enhancing PPAR&#x003b3; activity, thus antagonizing NF-&#x003ba;B or AP-1 activation and indirectly reducing inflammation (<xref rid="ref117" ref-type="bibr">117</xref>, <xref rid="ref118" ref-type="bibr">118</xref>). The sole RCT included on quercetin treatment for NAFLD involves patients taking 500&#x0202f;mg of quercetin daily for 12&#x0202f;weeks, and no adverse effects are observed (<xref rid="ref75" ref-type="bibr">75</xref>). Other clinical studies report minimal adverse effects of quercetin. Nonetheless, the safety of long-term (&#x0003e;12&#x0202f;weeks) high-dose (&#x02265;1,000&#x0202f;mg) supplementation needs further evaluation (<xref rid="ref119" ref-type="bibr">119</xref>). A pharmacokinetic study indicates that the bioavailability of a single oral dose of quercetin is very low (approximately 2%). This may be ascribed to factors like reduced absorption rates, extensive metabolism, and/or rapid elimination (<xref rid="ref117" ref-type="bibr">117</xref>).</p><p>The MD has been proven to be a healthy eating pattern that can improve blood lipids and liver enzymes, and reverse IR in patients with NAFLD (<xref rid="ref120" ref-type="bibr">120</xref>&#x02013;<xref rid="ref122" ref-type="bibr">122</xref>). The MD is marked by food diversity, including fruits, vegetables, legumes, spices, and herbs. The health benefits are attributed to its rich content of dietary polyphenols with anti-inflammatory and antioxidant effects (<xref rid="ref123" ref-type="bibr">123</xref>, <xref rid="ref124" ref-type="bibr">124</xref>). Given the absence of consistent evidence on the effective dosage and safety of isolated dietary polyphenol monomers, it is recommended for NAFLD patients to follow the MD, which is a safer, more affordable, and easier-to-maintain adjunctive therapy. However, before starting the MD, it is still important to seek the advice and guidance of a nutritionist or doctor based on one&#x02019;s health condition to ensure safety and effectiveness.</p><p>This study compared the effects of different dietary polyphenol supplements on NAFLD, including 54 RCTs with 3,132 patients, offering a large sample size. Nonetheless, this study also presents certain limitations. Firstly, the network diagram has not formed a loop, and there is insufficient evidence for direct comparisons of various dietary polyphenols. Secondly, although this study shows that DHM and quercetin have markable effects, the number of samples available for research is very limited. Finally, the literature included in this study exhibits an imbalance in regional distribution. There are differences among various regions regarding healthcare systems, methods for diagnosing and assessing NAFLD, as well as laboratory testing indicators. The above limitations could impact the reliability of the findings in this study.</p></sec><sec sec-type="conclusions" id="sec26"><label>5</label><title>Conclusion</title><p>This study indicates that catechin, naringenin, DHM, and quercetin are dietary polyphenols that demonstrate notable efficacy in improving metabolic and inflammatory markers in patients with NAFLD. Among these, catechin appears to comprehensively enhance BMI, liver enzymes, and blood lipids linked to NAFLD, suggesting it may be the most suitable dietary polyphenol supplement. These findings provide preliminary recommendations and reliable evidence for healthcare professionals or nutritionists advocating for the use of dietary polyphenol supplements or polyphenol-rich diets as adjunctive therapies for NAFLD. The focus of future studies may, on the one hand, still be based on well-designed and rigorous RCTs to provide adequate sample sizes that can be employed for analyses. This is particularly important for dietary polyphenols that the current study has identified as most efficacious but which are limited by small sample sizes (like DHM and quercetin). On the other hand, given the uncertainties surrounding the safety of dietary polyphenols and their relatively low bioavailability, it may be beneficial to utilize RCTs to examine the incidence of adverse reactions tied to these compounds in order to better understand their safety profiles. Or, conducting a meta-analysis of clinical studies related to specific dietary polyphenols could help summarize effective strategies for maximizing their bioavailability in humans, determining the lowest effective doses, and addressing long-term administration safety concerns.</p></sec></body><back><fn-group><fn id="fn0001"><p>
<sup>1</sup>
<ext-link xlink:href="https://www.crd.york.ac.uk/PROSPERO/" ext-link-type="uri">https://www.crd.york.ac.uk/PROSPERO/</ext-link>
</p></fn><fn id="fn0002"><p>
<sup>2</sup>
<ext-link xlink:href="http://phenol-explorer.eu/" ext-link-type="uri">http://phenol-explorer.eu/</ext-link>
</p></fn></fn-group><sec sec-type="author-contributions" id="sec27"><title>Author contributions</title><p>X-cW: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. LS: Conceptualization, Data curation, Investigation, Supervision, Validation, Visualization, Writing &#x02013; review &#x00026; editing. X-hW: Formal analysis, Investigation, Methodology, Resources, Software, Writing &#x02013; original draft.</p></sec><sec sec-type="COI-statement" id="sec29"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec30"><title>Generative AI statement</title><p>The authors declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="sec31"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="sec32"><title>Supplementary material</title><p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnut.2025.1582861/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnut.2025.1582861/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Table_1.docx"/></supplementary-material><supplementary-material id="SM2" position="float" content-type="local-data"><media xlink:href="Table_2.docx"/></supplementary-material><supplementary-material id="SM3" position="float" content-type="local-data"><media xlink:href="Data_Sheet_1.zip"/></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab id="coll1">European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)</collab></person-group>. <article-title>EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease</article-title>. <source>J Hepatol</source>. (<year>2016</year>) <volume>64</volume>:<fpage>1388</fpage>&#x02013;<lpage>402</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2015.11.004</pub-id>, PMID: <pub-id pub-id-type="pmid">27062661</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzzetti</surname><given-names>E</given-names></name><name><surname>Pinzani</surname><given-names>M</given-names></name><name><surname>Tsochatzis</surname><given-names>EA</given-names></name></person-group>. <article-title>The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)</article-title>. <source>Metabolism</source>. (<year>2016</year>) <volume>65</volume>:<fpage>1038</fpage>&#x02013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.metabol.2015.12.012</pub-id>, PMID: <pub-id pub-id-type="pmid">26823198</pub-id>
</mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younossi</surname><given-names>ZM</given-names></name><name><surname>Golabi</surname><given-names>P</given-names></name><name><surname>Paik</surname><given-names>JM</given-names></name><name><surname>Henry</surname><given-names>A</given-names></name><name><surname>Van Dongen</surname><given-names>C</given-names></name><name><surname>Henry</surname><given-names>L</given-names></name></person-group>. <article-title>The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review</article-title>. <source>Hepatology</source>. (<year>2023</year>) <volume>77</volume>:<fpage>1335</fpage>&#x02013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1097/HEP.0000000000000004</pub-id>, PMID: <pub-id pub-id-type="pmid">36626630</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>B</given-names></name><name><surname>Yeo</surname><given-names>YH</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><etal/></person-group>. <article-title>Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999&#x02013;2019: a systematic review and meta-analysis</article-title>. <source>Lancet Gastroenterol Hepatol</source>. (<year>2019</year>) <volume>4</volume>:<fpage>389</fpage>&#x02013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2468-1253(19)30039-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30902670</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>AM</given-names></name><name><surname>Hicks</surname><given-names>SB</given-names></name><name><surname>Mara</surname><given-names>KC</given-names></name><name><surname>Larson</surname><given-names>JJ</given-names></name><name><surname>Therneau</surname><given-names>TM</given-names></name></person-group>. <article-title>The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity&#x02014;a longitudinal cohort study</article-title>. <source>J Hepatol</source>. (<year>2019</year>) <volume>71</volume>:<fpage>1229</fpage>&#x02013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2019.08.018</pub-id>, PMID: <pub-id pub-id-type="pmid">31470068</pub-id>
</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JA</given-names></name><name><surname>Kendall</surname><given-names>BJ</given-names></name><name><surname>Dalais</surname><given-names>C</given-names></name><name><surname>Macdonald</surname><given-names>GA</given-names></name><name><surname>Thrift</surname><given-names>AP</given-names></name></person-group>. <article-title>Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis</article-title>. <source>Eur J Cancer</source>. (<year>2022</year>) <volume>173</volume>:<fpage>250</fpage>&#x02013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejca.2022.06.051</pub-id>, PMID: <pub-id pub-id-type="pmid">35944373</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cholankeril</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Perumpail</surname><given-names>RB</given-names></name><name><surname>Yoo</surname><given-names>ER</given-names></name><name><surname>Puri</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes</article-title>. <source>Dig Dis Sci</source>. (<year>2017</year>) <volume>62</volume>:<fpage>2915</fpage>&#x02013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10620-017-4684-x</pub-id><pub-id pub-id-type="pmid">28744836</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab id="coll2">European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)</collab></person-group>. <article-title>EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)</article-title>. <source>J Hepatol</source>. (<year>2024</year>) <volume>81</volume>:<fpage>492</fpage>&#x02013;<lpage>542</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2024.04.031</pub-id>, PMID: <pub-id pub-id-type="pmid">38851997</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paik</surname><given-names>JM</given-names></name><name><surname>Golabi</surname><given-names>P</given-names></name><name><surname>Younossi</surname><given-names>Y</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Younossi</surname><given-names>ZM</given-names></name></person-group>. <article-title>Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD</article-title>. <source>Hepatology</source>. (<year>2020</year>) <volume>72</volume>:<fpage>1605</fpage>&#x02013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep.31173</pub-id>, PMID: <pub-id pub-id-type="pmid">32043613</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keam</surname><given-names>SJ</given-names></name></person-group>. <article-title>Resmetirom: first approval</article-title>. <source>Drugs</source>. (<year>2024</year>) <volume>84</volume>:<fpage>729</fpage>&#x02013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40265-024-02045-0</pub-id><pub-id pub-id-type="pmid">38771485</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younossi</surname><given-names>ZM</given-names></name><name><surname>Zelber-Sagi</surname><given-names>S</given-names></name><name><surname>Henry</surname><given-names>L</given-names></name><name><surname>Gerber</surname><given-names>LH</given-names></name></person-group>. <article-title>Lifestyle interventions in nonalcoholic fatty liver disease</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. (<year>2023</year>) <volume>20</volume>:<fpage>708</fpage>&#x02013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41575-023-00800-4</pub-id><pub-id pub-id-type="pmid">37402873</pub-id>
</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ouyang</surname><given-names>Z</given-names></name><name><surname>Du</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>New opportunities and challenges of natural products research: when target identification meets single-cell multiomics</article-title>. <source>Acta Pharm Sin B</source>. (<year>2022</year>) <volume>12</volume>:<fpage>4011</fpage>&#x02013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.apsb.2022.08.022</pub-id>, PMID: <pub-id pub-id-type="pmid">36386472</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abenavoli</surname><given-names>L</given-names></name><name><surname>Larussa</surname><given-names>T</given-names></name><name><surname>Corea</surname><given-names>A</given-names></name><name><surname>Procopio</surname><given-names>AC</given-names></name><name><surname>Boccuto</surname><given-names>L</given-names></name><name><surname>Dallio</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Dietary polyphenols and non-alcoholic fatty liver disease</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>494</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13020494</pub-id>, PMID: <pub-id pub-id-type="pmid">33546130</pub-id>
</mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Ge</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>949746</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.949746</pub-id>, PMID: <pub-id pub-id-type="pmid">36159792</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>J</given-names></name><name><surname>Del Giovane</surname><given-names>C</given-names></name></person-group>. <article-title>Network meta-analysis</article-title>. <source>Methods Mol Biol</source>. (<year>2022</year>) <volume>2345</volume>:<fpage>187</fpage>&#x02013;<lpage>201</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-0716-1566-9_12</pub-id>, PMID: <pub-id pub-id-type="pmid">34550592</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutton</surname><given-names>B</given-names></name><name><surname>Salanti</surname><given-names>G</given-names></name><name><surname>Caldwell</surname><given-names>DM</given-names></name><name><surname>Chaimani</surname><given-names>A</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><name><surname>Cameron</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations</article-title>. <source>Ann Intern Med</source>. (<year>2015</year>) <volume>162</volume>:<fpage>777</fpage>&#x02013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.7326/M14-2385</pub-id>, PMID: <pub-id pub-id-type="pmid">26030634</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JAC</given-names></name><name><surname>Savovi&#x00107;</surname><given-names>J</given-names></name><name><surname>Page</surname><given-names>MJ</given-names></name><name><surname>Elbers</surname><given-names>RG</given-names></name><name><surname>Blencowe</surname><given-names>NS</given-names></name><name><surname>Boutron</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title>. <source>BMJ</source>. (<year>2019</year>) <volume>366</volume>:<fpage>l4898</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id>, PMID: <pub-id pub-id-type="pmid">31462531</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>RM</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Higgins</surname><given-names>JP</given-names></name></person-group>. <article-title>Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis</article-title>. <source>Stat Med</source>. (<year>2015</year>) <volume>34</volume>:<fpage>984</fpage>&#x02013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.6381</pub-id>, PMID: <pub-id pub-id-type="pmid">25475839</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melsen</surname><given-names>WG</given-names></name><name><surname>Bootsma</surname><given-names>MC</given-names></name><name><surname>Rovers</surname><given-names>MM</given-names></name><name><surname>Bonten</surname><given-names>MJ</given-names></name></person-group>. <article-title>The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses</article-title>. <source>Clin Microbiol Infect</source>. (<year>2014</year>) <volume>20</volume>:<fpage>123</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1469-0691.12494</pub-id>, PMID: <pub-id pub-id-type="pmid">24320992</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Riley</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>IR</given-names></name></person-group>. <article-title>Multivariate meta-analysis: potential and promise</article-title>. <source>Stat Med</source>. (<year>2011</year>) <volume>30</volume>:<fpage>2481</fpage>&#x02013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.4172</pub-id>, PMID: <pub-id pub-id-type="pmid">21268052</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salanti</surname><given-names>G</given-names></name><name><surname>Ades</surname><given-names>AE</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name></person-group>. <article-title>Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial</article-title>. <source>J Clin Epidemiol</source>. (<year>2011</year>) <volume>64</volume>:<fpage>163</fpage>&#x02013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">20688472</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaimani</surname><given-names>A</given-names></name><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Mavridis</surname><given-names>D</given-names></name><name><surname>Spyridonos</surname><given-names>P</given-names></name><name><surname>Salanti</surname><given-names>G</given-names></name></person-group>. <article-title>Graphical tools for network meta-analysis in STATA</article-title>. <source>PLoS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e76654</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0076654</pub-id>, PMID: <pub-id pub-id-type="pmid">24098547</pub-id>
</mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saadati</surname><given-names>S</given-names></name><name><surname>Hatami</surname><given-names>B</given-names></name><name><surname>Yari</surname><given-names>Z</given-names></name><name><surname>Shahrbaf</surname><given-names>MA</given-names></name><name><surname>Eghtesad</surname><given-names>S</given-names></name><name><surname>Mansour</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease</article-title>. <source>Eur J Clin Nutr</source>. (<year>2019</year>) <volume>73</volume>:<fpage>441</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41430-018-0382-9</pub-id>, PMID: <pub-id pub-id-type="pmid">30610213</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>G</given-names></name><name><surname>Dudhatra</surname><given-names>N</given-names></name><name><surname>Chhaya</surname><given-names>G</given-names></name></person-group>. <article-title>Evaluation of the safety and efficacy of CurcuVail<sup>&#x000ae;</sup> in patients with non-alcoholic fatty liver disease&#x02014;a prospective randomized, double blind, placebo controlled, parallel group study</article-title>. <source>Int J Green Pharm</source>. (<year>2023</year>) <volume>17</volume>:<fpage>218</fpage>&#x02013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.22377/ijgp.v17i03.3472</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y</given-names></name><name><surname>Valizadegan</surname><given-names>G</given-names></name><name><surname>Ahamdi</surname><given-names>N</given-names></name><name><surname>Ganjali</surname><given-names>S</given-names></name><name><surname>Majeed</surname><given-names>M</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Curcuminoids plus piperine improve nonalcoholic fatty liver disease: a clinical trial</article-title>. <source>J Cell Biochem</source>. (<year>2019</year>) <volume>120</volume>:<fpage>15989</fpage>&#x02013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcb.28877</pub-id>, PMID: <pub-id pub-id-type="pmid">31168845</pub-id>
</mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saberi-Karimian</surname><given-names>M</given-names></name><name><surname>Keshvari</surname><given-names>M</given-names></name><name><surname>Ghayour-Mobarhan</surname><given-names>M</given-names></name><name><surname>Salehizadeh</surname><given-names>L</given-names></name><name><surname>Rahmani</surname><given-names>S</given-names></name><name><surname>Behnam</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>Complement Ther Med</source>. (<year>2020</year>) <volume>49</volume>:<fpage>102322</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ctim.2020.102322</pub-id>, PMID: <pub-id pub-id-type="pmid">32147075</pub-id>
</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirhafez</surname><given-names>SR</given-names></name><name><surname>Dehabeh</surname><given-names>M</given-names></name><name><surname>Hariri</surname><given-names>M</given-names></name><name><surname>Farimani</surname><given-names>AR</given-names></name><name><surname>Movahedi</surname><given-names>A</given-names></name><name><surname>Naderan</surname><given-names>RD</given-names></name><etal/></person-group>. <article-title>Curcumin and piperine combination for the treatment of patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled trial</article-title>. <source>Adv Exp Med Biol</source>. (<year>2021</year>) <volume>1328</volume>:<fpage>11</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-030-73234-9_2</pub-id>, PMID: <pub-id pub-id-type="pmid">34981468</pub-id>
</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>S</given-names></name><name><surname>Bagherniya</surname><given-names>M</given-names></name><name><surname>Khoram</surname><given-names>Z</given-names></name><name><surname>Ebrahimi Varzaneh</surname><given-names>A</given-names></name><name><surname>Atkin</surname><given-names>SL</given-names></name><name><surname>Jamialahmadi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: a double-blind, randomized, placebo-controlled clinical trial</article-title>. <source>Phytother Res</source>. (<year>2023</year>) <volume>37</volume>:<fpage>2217</fpage>&#x02013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.7764</pub-id>, PMID: <pub-id pub-id-type="pmid">36799355</pub-id>
</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaei</surname><given-names>L</given-names></name><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Shafaghi</surname><given-names>A</given-names></name><name><surname>Hojati</surname><given-names>A</given-names></name></person-group>. <article-title>Benefits of Pilates training and nano-curcumin supplementation for overweight and obese females with NAFLD: a pilot study</article-title>. <source>Forum Nutr</source>. (<year>2023</year>) <volume>48</volume>:<fpage>49</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s41110-023-00236-5</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jazayeri-Tehrani</surname><given-names>SA</given-names></name><name><surname>Rezayat</surname><given-names>SM</given-names></name><name><surname>Mansouri</surname><given-names>S</given-names></name><name><surname>Qorbani</surname><given-names>M</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name><name><surname>Daneshi-Maskooni</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial</article-title>. <source>Nutr Metab</source>. (<year>2019</year>) <volume>16</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12986-019-0331-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30705687</pub-id>
</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelardeh</surname><given-names>BM</given-names></name><name><surname>Rahmati-Ahmadabad</surname><given-names>S</given-names></name><name><surname>Farzanegi</surname><given-names>P</given-names></name><name><surname>Helalizadeh</surname><given-names>M</given-names></name><name><surname>Azarbayjani</surname><given-names>MA</given-names></name></person-group>. <article-title>Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease</article-title>. <source>J Bodyw Mov Ther</source>. (<year>2020</year>) <volume>24</volume>:<fpage>154</fpage>&#x02013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jbmt.2020.02.021</pub-id>, PMID: <pub-id pub-id-type="pmid">32825982</pub-id>
</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y</given-names></name><name><surname>Kianpour</surname><given-names>P</given-names></name><name><surname>Mohtashami</surname><given-names>R</given-names></name><name><surname>Jafari</surname><given-names>R</given-names></name><name><surname>Simental-Mend&#x000ed;a</surname><given-names>LE</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>J Cardiovasc Pharmacol</source>. (<year>2016</year>) <volume>68</volume>:<fpage>223</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1097/FJC.0000000000000406</pub-id>, PMID: <pub-id pub-id-type="pmid">27124606</pub-id>
</mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y</given-names></name><name><surname>Kianpour</surname><given-names>P</given-names></name><name><surname>Mohtashami</surname><given-names>R</given-names></name><name><surname>Jafari</surname><given-names>R</given-names></name><name><surname>Simental-Mend&#x000ed;a</surname><given-names>LE</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>Drug Res</source>. (<year>2017</year>) <volume>67</volume>:<fpage>244</fpage>&#x02013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0043-100019</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirhafez</surname><given-names>SR</given-names></name><name><surname>Azimi-Nezhad</surname><given-names>M</given-names></name><name><surname>Dehabeh</surname><given-names>M</given-names></name><name><surname>Hariri</surname><given-names>M</given-names></name><name><surname>Naderan</surname><given-names>RD</given-names></name><name><surname>Movahedi</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The effect of curcumin phytosome on the treatment of patients with non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial</article-title>. <source>Adv Exp Med Biol</source>. (<year>2021</year>) <volume>1308</volume>:<fpage>25</fpage>&#x02013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-030-64872-5_3</pub-id>, PMID: <pub-id pub-id-type="pmid">33861434</pub-id>
</mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinian</surname><given-names>SA</given-names></name><name><surname>Mehrzad</surname><given-names>J</given-names></name><name><surname>Mirhafez</surname><given-names>SR</given-names></name><name><surname>Saeedi</surname><given-names>J</given-names></name><name><surname>Zhiani</surname><given-names>R</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Evaluation of the effect of phytosomal curcuminoids on oxidative stress and inflammatory markers in NAFLD: a randomized double-blind placebo-controlled trial</article-title>. <source>J Funct Foods</source>. (<year>2022</year>) <volume>96</volume>:<fpage>105202</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jff.2022.105202</pub-id>, PMID: <pub-id pub-id-type="pmid">40276772</pub-id>
</mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safari</surname><given-names>Z</given-names></name><name><surname>Bagherniya</surname><given-names>M</given-names></name><name><surname>Khoram</surname><given-names>Z</given-names></name><name><surname>Ebrahimi Varzaneh</surname><given-names>A</given-names></name><name><surname>Heidari</surname><given-names>Z</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers</article-title>. <source>Front Nutr</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1163950</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2023.1163950</pub-id>, PMID: <pub-id pub-id-type="pmid">37275651</pub-id>
</mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navekar</surname><given-names>R</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Khoshbaten</surname><given-names>M</given-names></name></person-group>. <article-title>Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases</article-title>. <source>J Am Coll Nutr</source>. (<year>2017</year>) <volume>36</volume>:<fpage>261</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1080/07315724.2016.1267597</pub-id>, PMID: <pub-id pub-id-type="pmid">28443702</pub-id>
</mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Navekar</surname><given-names>R</given-names></name><name><surname>Sepehri</surname><given-names>B</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Ghavami</surname><given-names>SM</given-names></name></person-group>. <article-title>Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)</article-title>. <source>Int J Vitam Nutr Res</source>. (<year>2019</year>) <volume>89</volume>:<fpage>293</fpage>&#x02013;<lpage>302</lpage>. doi: <pub-id pub-id-type="doi">10.1024/0300-9831/a000568</pub-id>, PMID: <pub-id pub-id-type="pmid">31017556</pub-id>
</mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarhahzadeh</surname><given-names>M</given-names></name><name><surname>Alavinejad</surname><given-names>P</given-names></name><name><surname>Farsi</surname><given-names>F</given-names></name><name><surname>Husain</surname><given-names>D</given-names></name><name><surname>Rezazadeh</surname><given-names>A</given-names></name></person-group>. <article-title>The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial</article-title>. <source>Diabetol Metab Syndr</source>. (<year>2021</year>) <volume>13</volume>:<fpage>112</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13098-021-00731-7</pub-id>, PMID: <pub-id pub-id-type="pmid">34663438</pub-id>
</mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalhori</surname><given-names>A</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Navekar</surname><given-names>R</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Jafarabadi</surname><given-names>MA</given-names></name></person-group>. <article-title>Effect of turmeric supplementation on blood pressure and serum levels of Sirtuin 1 and adiponectin in patients with nonalcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial</article-title>. <source>Prev Nutr Food Sci</source>. (<year>2022</year>) <volume>27</volume>:<fpage>37</fpage>&#x02013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.3746/pnf.2022.27.1.37</pub-id>, PMID: <pub-id pub-id-type="pmid">35465117</pub-id>
</mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chachay</surname><given-names>VS</given-names></name><name><surname>Macdonald</surname><given-names>GA</given-names></name><name><surname>Martin</surname><given-names>JH</given-names></name><name><surname>Whitehead</surname><given-names>JP</given-names></name><name><surname>O&#x02019;Moore-Sullivan</surname><given-names>TM</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Resveratrol does not benefit patients with nonalcoholic fatty liver disease</article-title>. <source>Clin Gastroenterol Hepatol</source>. (<year>2014</year>) <volume>12</volume>:<fpage>2092</fpage>&#x02013;<lpage>2103.e6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2014.02.024</pub-id>, PMID: <pub-id pub-id-type="pmid">24582567</pub-id>
</mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Ran</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>Dig Liver Dis</source>. (<year>2015</year>) <volume>47</volume>:<fpage>226</fpage>&#x02013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.dld.2014.11.015</pub-id>, PMID: <pub-id pub-id-type="pmid">25577300</pub-id>
</mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heeb&#x000f8;ll</surname><given-names>S</given-names></name><name><surname>Kreuzfeldt</surname><given-names>M</given-names></name><name><surname>Hamilton-Dutoit</surname><given-names>S</given-names></name><name><surname>Kj&#x000e6;r Poulsen</surname><given-names>M</given-names></name><name><surname>St&#x000f8;dkilde-J&#x000f8;rgensen</surname><given-names>H</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease</article-title>. <source>Scand J Gastroenterol</source>. (<year>2016</year>) <volume>51</volume>:<fpage>456</fpage>&#x02013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.3109/00365521.2015.1107620</pub-id>, PMID: <pub-id pub-id-type="pmid">26784973</pub-id>
</mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzin</surname><given-names>L</given-names></name><name><surname>Asghari</surname><given-names>S</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Shirmohammadi</surname><given-names>M</given-names></name></person-group>. <article-title>No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease</article-title>. <source>Int J Vitam Nutr Res</source>. (<year>2020</year>) <volume>90</volume>:<fpage>279</fpage>&#x02013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1024/0300-9831/a000528</pub-id>, PMID: <pub-id pub-id-type="pmid">30789808</pub-id>
</mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faghihzadeh</surname><given-names>F</given-names></name><name><surname>Adibi</surname><given-names>P</given-names></name><name><surname>Rafiei</surname><given-names>R</given-names></name><name><surname>Hekmatdoost</surname><given-names>A</given-names></name></person-group>. <article-title>Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease</article-title>. <source>Nutr Res</source>. (<year>2014</year>) <volume>34</volume>:<fpage>837</fpage>&#x02013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nutres.2014.09.005</pub-id>, PMID: <pub-id pub-id-type="pmid">25311610</pub-id>
</mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faghihzadeh</surname><given-names>F</given-names></name><name><surname>Adibi</surname><given-names>P</given-names></name><name><surname>Hekmatdoost</surname><given-names>A</given-names></name></person-group>. <article-title>The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study</article-title>. <source>Br J Nutr</source>. (<year>2015</year>) <volume>114</volume>:<fpage>796</fpage>&#x02013;<lpage>803</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0007114515002433</pub-id>, PMID: <pub-id pub-id-type="pmid">26234526</pub-id>
</mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghari</surname><given-names>S</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Somi</surname><given-names>MH</given-names></name><name><surname>Ghavami</surname><given-names>SM</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name></person-group>. <article-title>Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum Sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial</article-title>. <source>J Am Coll Nutr</source>. (<year>2018</year>) <volume>37</volume>:<fpage>223</fpage>&#x02013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1080/07315724.2017.1392264</pub-id>, PMID: <pub-id pub-id-type="pmid">29313746</pub-id>
</mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghari</surname><given-names>S</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Farzin</surname><given-names>L</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Ghavami</surname><given-names>SM</given-names></name><name><surname>Somi</surname><given-names>MH</given-names></name></person-group>. <article-title>Effects of pharmacologic dose of resveratrol supplementation on oxidative/antioxidative status biomarkers in nonalcoholic fatty liver disease patients: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Adv Pharm Bull</source>. (<year>2018</year>) <volume>8</volume>:<fpage>307</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.15171/apb.2018.036</pub-id>, PMID: <pub-id pub-id-type="pmid">30023333</pub-id>
</mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>PW</given-names></name><name><surname>Chen</surname><given-names>FX</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Ling</surname><given-names>WH</given-names></name><name><surname>Guo</surname><given-names>HH</given-names></name></person-group>. <article-title>A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease</article-title>. <source>Medicine</source>. (<year>2015</year>) <volume>94</volume>:<fpage>e758</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000000758</pub-id>, PMID: <pub-id pub-id-type="pmid">25997043</pub-id>
</mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izadi</surname><given-names>F</given-names></name><name><surname>Farrokhzad</surname><given-names>A</given-names></name><name><surname>Tamizifar</surname><given-names>B</given-names></name><name><surname>Tarrahi</surname><given-names>MJ</given-names></name><name><surname>Entezari</surname><given-names>MH</given-names></name></person-group>. <article-title>Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: a double-blind randomized controlled clinical trial</article-title>. <source>Phytother Res</source>. (<year>2021</year>) <volume>35</volume>:<fpage>477</fpage>&#x02013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.6826</pub-id>, PMID: <pub-id pub-id-type="pmid">32909326</pub-id>
</mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sangsefidi</surname><given-names>ZS</given-names></name><name><surname>Yarhosseini</surname><given-names>F</given-names></name><name><surname>Hosseinzadeh</surname><given-names>M</given-names></name><name><surname>Ranjbar</surname><given-names>A</given-names></name><name><surname>Akhondi-Meybodi</surname><given-names>M</given-names></name><name><surname>Fallahzadeh</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>The effect of (<italic>Cornus mas</italic> L.) fruit extract on liver function among patients with nonalcoholic fatty liver: a double-blind randomized clinical trial</article-title>. <source>Phytother Res</source>. (<year>2021</year>) <volume>35</volume>:<fpage>5259</fpage>&#x02013;<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.7199</pub-id>, PMID: <pub-id pub-id-type="pmid">34254372</pub-id>
</mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mojiri-Forushani</surname><given-names>HHA</given-names></name><name><surname>Khanzadeh</surname><given-names>A</given-names></name><name><surname>Zahedi</surname><given-names>A</given-names></name></person-group>. <article-title>Effectiveness of grape seed extract in patients with nonalcoholic fatty liver: a randomized double-blind clinical study</article-title>. <source>Hepat Mon</source>. (<year>2022</year>) <volume>22</volume>:<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.5812/hepatmon-132309</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarhosseini</surname><given-names>F</given-names></name><name><surname>Sangouni</surname><given-names>AA</given-names></name><name><surname>Sangsefidi</surname><given-names>ZS</given-names></name><name><surname>Hosseinzadeh</surname><given-names>M</given-names></name><name><surname>Akhondi-Meybodi</surname><given-names>M</given-names></name><name><surname>Ranjbar</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Effect of <italic>Cornus mas</italic> L. fruit extract on blood pressure, anthropometric and body composition indices in patients with non-alcoholic fatty liver disease: a double-blind randomized controlled trial</article-title>. <source>Clin Nutr ESPEN</source>. (<year>2023</year>) <volume>56</volume>:<fpage>18</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnesp.2023.04.018</pub-id>, PMID: <pub-id pub-id-type="pmid">37344070</pub-id>
</mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>SJ</given-names></name><name><surname>Eskandar</surname><given-names>H</given-names></name><name><surname>Sardabi</surname><given-names>EH</given-names></name></person-group>. <article-title>A placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease</article-title>. <source>Hepat Mon</source>. (<year>2009</year>) <volume>9</volume>:<fpage>265</fpage>&#x02013;<lpage>70</lpage>.</mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masoodi</surname><given-names>MRA</given-names></name><name><surname>Panahian</surname><given-names>M</given-names></name><name><surname>Vojdanian</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of silymarin on reducing liver aminotransferases in patients with nonalcoholic fatty liver diseases</article-title>. <source>GOVARESH</source>. (<year>2013</year>) <volume>18</volume>:<fpage>181</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solhi</surname><given-names>H</given-names></name><name><surname>Ghahremani</surname><given-names>R</given-names></name><name><surname>Kazemifar</surname><given-names>AM</given-names></name><name><surname>Hoseini</surname><given-names>YZ</given-names></name></person-group>. <article-title>Silymarin in treatment of non-alcoholic steatohepatitis: a randomized clinical trial</article-title>. <source>Caspian J Intern Med</source>. (<year>2014</year>) <volume>5</volume>:<fpage>9</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">24490006</pub-id>
</mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wah Kheong</surname><given-names>C</given-names></name><name><surname>Nik Mustapha</surname><given-names>NR</given-names></name><name><surname>Mahadeva</surname><given-names>S</given-names></name></person-group>. <article-title>A randomized trial of Silymarin for the treatment of nonalcoholic steatohepatitis</article-title>. <source>Clin Gastroenterol Hepatol</source>. (<year>2017</year>) <volume>15</volume>:<fpage>1940</fpage>&#x02013;<lpage>9.e8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2017.04.016</pub-id>, PMID: <pub-id pub-id-type="pmid">28419855</pub-id>
</mixed-citation></ref><ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anushiravani</surname><given-names>A</given-names></name><name><surname>Haddadi</surname><given-names>N</given-names></name><name><surname>Pourfarmanbar</surname><given-names>M</given-names></name><name><surname>Mohammadkarimi</surname><given-names>V</given-names></name></person-group>. <article-title>Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial</article-title>. <source>Eur J Gastroenterol Hepatol</source>. (<year>2019</year>) <volume>31</volume>:<fpage>613</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MEG.0000000000001369</pub-id>, PMID: <pub-id pub-id-type="pmid">30920975</pub-id>
</mixed-citation></ref><ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>R</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Torimura</surname><given-names>T</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Sata</surname><given-names>M</given-names></name></person-group>. <article-title>Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study</article-title>. <source>Int J Mol Med</source>. (<year>2013</year>) <volume>32</volume>:<fpage>989</fpage>&#x02013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.3892/ijmm.2013.1503</pub-id>, PMID: <pub-id pub-id-type="pmid">24065295</pub-id>
</mixed-citation></ref><ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezeshki</surname><given-names>A</given-names></name><name><surname>Safi</surname><given-names>S</given-names></name><name><surname>Feizi</surname><given-names>A</given-names></name><name><surname>Askari</surname><given-names>G</given-names></name><name><surname>Karami</surname><given-names>F</given-names></name></person-group>. <article-title>The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease</article-title>. <source>Int J Prev Med</source>. (<year>2016</year>) <volume>7</volume>:<fpage>28</fpage>. doi: <pub-id pub-id-type="doi">10.4103/2008-7802.173051</pub-id>, PMID: <pub-id pub-id-type="pmid">26955458</pub-id>
</mixed-citation></ref><ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Habib Ur</surname><given-names>R</given-names></name><name><surname>Akhtar</surname><given-names>L</given-names></name></person-group>. <article-title>Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients</article-title>. <source>Pak J Med Sci</source>. (<year>2017</year>) <volume>33</volume>:<fpage>931</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.12669/pjms.334.12571</pub-id>, PMID: <pub-id pub-id-type="pmid">29067068</pub-id>
</mixed-citation></ref><ref id="ref62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabatabaee</surname><given-names>SM</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name><name><surname>Ghalichi</surname><given-names>L</given-names></name><name><surname>Miryounesi</surname><given-names>SM</given-names></name><name><surname>Mousavizadeh</surname><given-names>K</given-names></name><name><surname>Jazayeri</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Green tea in non-alcoholic fatty liver disease: a double blind randomized clinical trial</article-title>. <source>Hepat Mon</source>. (<year>2017</year>) <volume>17</volume>:<fpage>6</fpage>. doi: <pub-id pub-id-type="doi">10.5812/hepatmon.14993</pub-id>, PMID: <pub-id pub-id-type="pmid">39416803</pub-id>
</mixed-citation></ref><ref id="ref63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahmohammadi</surname><given-names>HA</given-names></name><name><surname>Hosseini</surname><given-names>SA</given-names></name><name><surname>Hajiani</surname><given-names>E</given-names></name><name><surname>Malehi</surname><given-names>AS</given-names></name><name><surname>Alipour</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial</article-title>. <source>Hepat Mon</source>. (<year>2017</year>) <volume>63</volume>:<fpage>e12299</fpage>. doi: <pub-id pub-id-type="doi">10.5812/hepatmon.45609</pub-id></mixed-citation></ref><ref id="ref64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinabadi</surname><given-names>S</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Asgbari-Jafarabadi</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of green coffee extract supplementation on blood pressure and antioxidants status in patients with non-alcoholic fatty liver disease</article-title>. <source>Prog Nutr</source>. (<year>2019</year>) <volume>21</volume>:<fpage>180</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.23751/pn.v21i2-S.7267</pub-id></mixed-citation></ref><ref id="ref65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinabadi</surname><given-names>S</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Asghari</surname><given-names>S</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Vojouhi</surname><given-names>S</given-names></name></person-group>. <article-title>Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: a randomized, controlled trial</article-title>. <source>Complement Ther Med</source>. (<year>2020</year>) <volume>49</volume>:<fpage>102290</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ctim.2019.102290</pub-id>, PMID: <pub-id pub-id-type="pmid">32147076</pub-id>
</mixed-citation></ref><ref id="ref66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinabadi</surname><given-names>S</given-names></name><name><surname>Rafraf</surname><given-names>M</given-names></name><name><surname>Mahmoodzadeh</surname><given-names>A</given-names></name><name><surname>Asghari-Jafarabadi</surname><given-names>M</given-names></name><name><surname>Asghari</surname><given-names>S</given-names></name></person-group>. <article-title>Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease</article-title>. <source>J Herb Med</source>. (<year>2020</year>) <volume>22</volume>:<fpage>100340</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.hermed.2020.100340</pub-id>, PMID: <pub-id pub-id-type="pmid">40276772</pub-id>
</mixed-citation></ref><ref id="ref67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>R</given-names></name><name><surname>Jafarirad</surname><given-names>S</given-names></name><name><surname>Mohammadtaghvaei</surname><given-names>N</given-names></name><name><surname>Dastoorpoor</surname><given-names>M</given-names></name><name><surname>Alavinejad</surname><given-names>P</given-names></name></person-group>. <article-title>The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: a randomized double-blind clinical trial</article-title>. <source>Phytother Res</source>. (<year>2021</year>) <volume>35</volume>:<fpage>5871</fpage>&#x02013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.7249</pub-id>, PMID: <pub-id pub-id-type="pmid">34498307</pub-id>
</mixed-citation></ref><ref id="ref68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barghchi</surname><given-names>H</given-names></name><name><surname>Milkarizi</surname><given-names>N</given-names></name><name><surname>Belyani</surname><given-names>S</given-names></name><name><surname>Norouzian Ostad</surname><given-names>A</given-names></name><name><surname>Askari</surname><given-names>VR</given-names></name><name><surname>Rajabzadeh</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Pomegranate (<italic>Punica granatum</italic> L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial</article-title>. <source>Nutr J</source>. (<year>2023</year>) <volume>22</volume>:<fpage>40</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12937-023-00869-2</pub-id>, PMID: <pub-id pub-id-type="pmid">37605174</pub-id>
</mixed-citation></ref><ref id="ref69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amanat</surname><given-names>S</given-names></name><name><surname>Eftekhari</surname><given-names>MH</given-names></name><name><surname>Fararouei</surname><given-names>M</given-names></name><name><surname>Bagheri Lankarani</surname><given-names>K</given-names></name><name><surname>Massoumi</surname><given-names>SJ</given-names></name></person-group>. <article-title>Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: a randomized, controlled trial</article-title>. <source>Clin Nutr</source>. (<year>2018</year>) <volume>37</volume>:<fpage>1210</fpage>&#x02013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2017.05.028</pub-id>, PMID: <pub-id pub-id-type="pmid">28647291</pub-id>
</mixed-citation></ref><ref id="ref70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neshatbini Tehrani</surname><given-names>A</given-names></name><name><surname>Hatami</surname><given-names>B</given-names></name><name><surname>Helli</surname><given-names>B</given-names></name><name><surname>Yari</surname><given-names>Z</given-names></name><name><surname>Daftari</surname><given-names>G</given-names></name><name><surname>Salehpour</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>:<fpage>5134</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-55747-6</pub-id>, PMID: <pub-id pub-id-type="pmid">38429385</pub-id>
</mixed-citation></ref><ref id="ref71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namkhah</surname><given-names>Z</given-names></name><name><surname>Naeini</surname><given-names>F</given-names></name><name><surname>Mahdi Rezayat</surname><given-names>S</given-names></name><name><surname>Mehdi</surname><given-names>Y</given-names></name><name><surname>Mansouri</surname><given-names>S</given-names></name><name><surname>Javad Hosseinzadeh-Attar</surname><given-names>M</given-names></name></person-group>. <article-title>Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial</article-title>. <source>Int J Clin Pract</source>. (<year>2021</year>) <volume>75</volume>:<fpage>e14852</fpage>. doi: <pub-id pub-id-type="doi">10.1111/ijcp.14852</pub-id>, PMID: <pub-id pub-id-type="pmid">34516703</pub-id>
</mixed-citation></ref><ref id="ref72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeini</surname><given-names>F</given-names></name><name><surname>Namkhah</surname><given-names>Z</given-names></name><name><surname>Tutunchi</surname><given-names>H</given-names></name><name><surname>Rezayat</surname><given-names>SM</given-names></name><name><surname>Mansouri</surname><given-names>S</given-names></name><name><surname>Yaseri</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial</article-title>. <source>Eur J Gastroenterol Hepatol</source>. (<year>2022</year>) <volume>34</volume>:<fpage>345</fpage>&#x02013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MEG.0000000000002323</pub-id>, PMID: <pub-id pub-id-type="pmid">34860705</pub-id>
</mixed-citation></ref><ref id="ref73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Ran</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>Pharmacol Res</source>. (<year>2015</year>) <volume>99</volume>:<fpage>74</fpage>&#x02013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2015.05.009</pub-id>, PMID: <pub-id pub-id-type="pmid">26032587</pub-id>
</mixed-citation></ref><ref id="ref74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheraghpour</surname><given-names>M</given-names></name><name><surname>Imani</surname><given-names>H</given-names></name><name><surname>Ommi</surname><given-names>S</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name><name><surname>Karimi-Shahrbabak</surname><given-names>E</given-names></name><name><surname>Hedayati</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial</article-title>. <source>Phytother Res</source>. (<year>2019</year>) <volume>33</volume>:<fpage>2118</fpage>&#x02013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.6406</pub-id>, PMID: <pub-id pub-id-type="pmid">31264313</pub-id>
</mixed-citation></ref><ref id="ref75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinikia</surname><given-names>M</given-names></name><name><surname>Oubari</surname><given-names>F</given-names></name><name><surname>Hosseinkia</surname><given-names>R</given-names></name><name><surname>Tabeshfar</surname><given-names>Z</given-names></name><name><surname>Salehi</surname><given-names>MG</given-names></name><name><surname>Mousavian</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Quercetin supplementation in non-alcoholic fatty liver disease a randomized, double-blind, placebo-controlled clinical trial</article-title>. <source>Nutr Food Sci</source>. (<year>2020</year>) <volume>50</volume>:<fpage>1279</fpage>&#x02013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1108/NFS-10-2019-0321</pub-id></mixed-citation></ref><ref id="ref76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendra</surname><given-names>VKP</given-names></name><name><surname>Kurapati</surname><given-names>S</given-names></name><name><surname>Balineni</surname><given-names>SK</given-names></name><name><surname>Gogineni</surname><given-names>NTT</given-names></name></person-group>. <article-title>A blend of Sphaeranthus indicus flower head and <italic>Terminalia chebula</italic> fruit extracts reduces fatty liver and improves liver function in non-alcoholic, overweight adults</article-title>. <source>Funct Foods Health D</source>. (<year>2022</year>) <volume>12</volume>:<fpage>361</fpage>&#x02013;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.31989/ffhd.v12i7.958</pub-id></mixed-citation></ref><ref id="ref77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Effects of different natural products in patients with non-alcoholic fatty liver disease-a network meta-analysis of randomized controlled trials</article-title>. <source>Phytother Res</source>. (<year>2024</year>) <volume>38</volume>:<fpage>3801</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.8182</pub-id>, PMID: <pub-id pub-id-type="pmid">38886838</pub-id>
</mixed-citation></ref><ref id="ref78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>MH</given-names></name><name><surname>Le</surname><given-names>DM</given-names></name><name><surname>Baez</surname><given-names>TC</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>EY</given-names></name><etal/></person-group>. <article-title>Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons</article-title>. <source>J Hepatol</source>. (<year>2023</year>) <volume>79</volume>:<fpage>287</fpage>&#x02013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2023.03.040</pub-id>, PMID: <pub-id pub-id-type="pmid">37040843</pub-id>
</mixed-citation></ref><ref id="ref79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isemura</surname><given-names>M</given-names></name></person-group>. <article-title>Catechin in human health and disease</article-title>. <source>Molecules</source>. (<year>2019</year>) <volume>24</volume>:<fpage>528</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules24030528</pub-id>, PMID: <pub-id pub-id-type="pmid">30717121</pub-id>
</mixed-citation></ref><ref id="ref80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>Mechanisms of body weight reduction and metabolic syndrome alleviation by tea</article-title>. <source>Mol Nutr Food Res</source>. (<year>2016</year>) <volume>60</volume>:<fpage>160</fpage>&#x02013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.201500428</pub-id>, PMID: <pub-id pub-id-type="pmid">26577614</pub-id>
</mixed-citation></ref><ref id="ref81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>EGCG reduces obesity and white adipose tissue gain partly through AMPK activation in mice</article-title>. <source>Front Pharmacol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>1366</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2018.01366</pub-id>, PMID: <pub-id pub-id-type="pmid">30524290</pub-id>
</mixed-citation></ref><ref id="ref82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Chan</surname><given-names>MH</given-names></name><name><surname>Yang</surname><given-names>YF</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Hsiao</surname><given-names>M</given-names></name></person-group>. <article-title>Glucose transporter 4: insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression</article-title>. <source>Cancer Lett</source>. (<year>2023</year>) <volume>563</volume>:<fpage>216179</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canlet.2023.216179</pub-id>, PMID: <pub-id pub-id-type="pmid">37061122</pub-id>
</mixed-citation></ref><ref id="ref83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>XY</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>ZY</given-names></name><name><surname>Li</surname><given-names>HY</given-names></name><name><surname>Li</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study</article-title>. <source>Lipids Health Dis</source>. (<year>2019</year>) <volume>18</volume>:<fpage>47</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-019-0984-9</pub-id>, PMID: <pub-id pub-id-type="pmid">30744645</pub-id>
</mixed-citation></ref><ref id="ref84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>H</given-names></name><name><surname>Craig</surname><given-names>D</given-names></name><name><surname>Barker</surname><given-names>R</given-names></name><name><surname>Spiers</surname><given-names>G</given-names></name><name><surname>Stow</surname><given-names>D</given-names></name><name><surname>Anstee</surname><given-names>QM</given-names></name><etal/></person-group>. <article-title>Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies</article-title>. <source>PLoS Med</source>. (<year>2020</year>) <volume>17</volume>:<fpage>e1003100</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1003100</pub-id>, PMID: <pub-id pub-id-type="pmid">32353039</pub-id>
</mixed-citation></ref><ref id="ref85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Kuang</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis</article-title>. <source>J Transl Med</source>. (<year>2023</year>) <volume>21</volume>:<fpage>192</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-023-04047-0</pub-id>, PMID: <pub-id pub-id-type="pmid">36915168</pub-id>
</mixed-citation></ref><ref id="ref86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Sui</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Effects of green tea catechin on the blood pressure and lipids in overweight and obese population-a meta-analysis</article-title>. <source>Heliyon</source>. (<year>2023</year>) <volume>9</volume>:<fpage>e21228</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e21228</pub-id>, PMID: <pub-id pub-id-type="pmid">38034724</pub-id>
</mixed-citation></ref><ref id="ref87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>XX</given-names></name><name><surname>Xu</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>SH</given-names></name><name><surname>Liu</surname><given-names>XX</given-names></name><name><surname>Hui</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>XH</given-names></name></person-group>. <article-title>Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials</article-title>. <source>Am J Clin Nutr</source>. (<year>2011</year>) <volume>94</volume>:<fpage>601</fpage>&#x02013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.3945/ajcn.110.010926</pub-id>, PMID: <pub-id pub-id-type="pmid">21715508</pub-id>
</mixed-citation></ref><ref id="ref88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name></person-group>. <article-title>Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway</article-title>. <source>Mol Cell Biochem</source>. (<year>2018</year>) <volume>448</volume>:<fpage>175</fpage>&#x02013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11010-018-3324-x</pub-id>, PMID: <pub-id pub-id-type="pmid">29446047</pub-id>
</mixed-citation></ref><ref id="ref89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name></person-group>. <article-title>Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): insights into the role of oxidative stress and antioxidant mechanism</article-title>. <source>Antioxidants</source>. (<year>2021</year>) <volume>10</volume>:<fpage>1076</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox10071076</pub-id><pub-id pub-id-type="pmid">34356308</pub-id>
</mixed-citation></ref><ref id="ref90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamber</surname><given-names>SS</given-names></name><name><surname>Bansal</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>RB</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name></person-group>. <article-title>Biomarkers of liver diseases</article-title>. <source>Mol Biol Rep</source>. (<year>2023</year>) <volume>50</volume>:<fpage>7815</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11033-023-08666-0</pub-id>, PMID: <pub-id pub-id-type="pmid">37482588</pub-id>
</mixed-citation></ref><ref id="ref91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepien</surname><given-names>M</given-names></name><name><surname>Fedirko</surname><given-names>V</given-names></name><name><surname>Duarte-Salles</surname><given-names>T</given-names></name><name><surname>Ferrari</surname><given-names>P</given-names></name><name><surname>Freisling</surname><given-names>H</given-names></name><name><surname>Trepo</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Prospective association of liver function biomarkers with development of hepatobiliary cancers</article-title>. <source>Cancer Epidemiol</source>. (<year>2016</year>) <volume>40</volume>:<fpage>179</fpage>&#x02013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canep.2016.01.002</pub-id>, PMID: <pub-id pub-id-type="pmid">26773278</pub-id>
</mixed-citation></ref><ref id="ref92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>YY</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name></person-group>. <article-title>Potential biological effects of (-)-epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease</article-title>. <source>Mol Nutr Food Res</source>. (<year>2018</year>) <volume>62</volume>:<fpage>1700483</fpage>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.201700483</pub-id>, PMID: <pub-id pub-id-type="pmid">28799714</pub-id>
</mixed-citation></ref><ref id="ref93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abunofal</surname><given-names>O</given-names></name><name><surname>Mohan</surname><given-names>C</given-names></name></person-group>. <article-title>Salubrious effects of green tea catechins on fatty liver disease: a systematic review</article-title>. <source>Medicines</source>. (<year>2022</year>) <volume>9</volume>:<fpage>20</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medicines9030020</pub-id>, PMID: <pub-id pub-id-type="pmid">35323719</pub-id>
</mixed-citation></ref><ref id="ref94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bessone</surname><given-names>F</given-names></name><name><surname>Razori</surname><given-names>MV</given-names></name><name><surname>Roma</surname><given-names>MG</given-names></name></person-group>. <article-title>Molecular pathways of nonalcoholic fatty liver disease development and progression</article-title>. <source>Cell Mol Life Sci</source>. (<year>2019</year>) <volume>76</volume>:<fpage>99</fpage>&#x02013;<lpage>128</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-018-2947-0</pub-id>, PMID: <pub-id pub-id-type="pmid">30343320</pub-id>
</mixed-citation></ref><ref id="ref95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>IJ</given-names></name><name><surname>Liu</surname><given-names>CY</given-names></name><name><surname>Chiu</surname><given-names>JP</given-names></name><name><surname>Hsu</surname><given-names>CH</given-names></name></person-group>. <article-title>Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial</article-title>. <source>Clin Nutr</source>. (<year>2016</year>) <volume>35</volume>:<fpage>592</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2015.05.003</pub-id>, PMID: <pub-id pub-id-type="pmid">26093535</pub-id>
</mixed-citation></ref><ref id="ref96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>IG</given-names></name><name><surname>Ali</surname><given-names>Z</given-names></name><name><surname>Abe</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>FD</given-names></name><name><surname>Hamada</surname><given-names>FM</given-names></name><name><surname>Abd-Ellah</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>Effect of green tea and its polyphenols on mouse liver</article-title>. <source>Fitoterapia</source>. (<year>2013</year>) <volume>90</volume>:<fpage>151</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fitote.2013.07.014</pub-id>, PMID: <pub-id pub-id-type="pmid">23892001</pub-id>
</mixed-citation></ref><ref id="ref97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucera</surname><given-names>O</given-names></name><name><surname>Mezera</surname><given-names>V</given-names></name><name><surname>Moravcova</surname><given-names>A</given-names></name><name><surname>Endlicher</surname><given-names>R</given-names></name><name><surname>Lotkova</surname><given-names>H</given-names></name><name><surname>Drahota</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title><italic>In vitro</italic> toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes</article-title>. <source>Oxid Med Cell Longev</source>. (<year>2015</year>) <volume>2015</volume>:<fpage>476180</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2015/476180</pub-id>, PMID: <pub-id pub-id-type="pmid">25918582</pub-id>
</mixed-citation></ref><ref id="ref98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>ZY</given-names></name><name><surname>Li</surname><given-names>XM</given-names></name><name><surname>Liang</surname><given-names>JP</given-names></name><name><surname>Xiang</surname><given-names>LP</given-names></name><name><surname>Wang</surname><given-names>KR</given-names></name><name><surname>Shi</surname><given-names>YL</given-names></name><etal/></person-group>. <article-title>Bioavailability of tea catechins and its improvement</article-title>. <source>Molecules</source>. (<year>2018</year>) <volume>23</volume>:<fpage>2346</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules23092346</pub-id>, PMID: <pub-id pub-id-type="pmid">30217074</pub-id>
</mixed-citation></ref><ref id="ref99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeini</surname><given-names>F</given-names></name><name><surname>Namkhah</surname><given-names>Z</given-names></name><name><surname>Ostadrahimi</surname><given-names>A</given-names></name><name><surname>Tutunchi</surname><given-names>H</given-names></name><name><surname>Hosseinzadeh-Attar</surname><given-names>MJ</given-names></name></person-group>. <article-title>A comprehensive systematic review of the effects of naringenin, a citrus-derived flavonoid, on risk factors for nonalcoholic fatty liver disease</article-title>. <source>Adv Nutr</source>. (<year>2021</year>) <volume>12</volume>:<fpage>413</fpage>&#x02013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmaa106</pub-id>, PMID: <pub-id pub-id-type="pmid">32879962</pub-id>
</mixed-citation></ref><ref id="ref100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Ou</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Wen</surname><given-names>C</given-names></name><name><surname>Yue</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-&#x003ba;B pathway in mice</article-title>. <source>Br J Pharmacol</source>. (<year>2020</year>) <volume>177</volume>:<fpage>1806</fpage>&#x02013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bph.14938</pub-id>, PMID: <pub-id pub-id-type="pmid">31758699</pub-id>
</mixed-citation></ref><ref id="ref101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>YQ</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>XL</given-names></name></person-group>. <article-title>Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe<sup>&#x02212;/&#x02212;</sup> mice: role of SIRT1</article-title>. <source>Phytomedicine</source>. (<year>2021</year>) <volume>81</volume>:<fpage>153412</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2020.153412</pub-id>, PMID: <pub-id pub-id-type="pmid">33234364</pub-id>
</mixed-citation></ref><ref id="ref102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats</article-title>. <source>Eur J Pharmacol</source>. (<year>2016</year>) <volume>773</volume>:<fpage>13</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.01.002</pub-id>, PMID: <pub-id pub-id-type="pmid">26801071</pub-id>
</mixed-citation></ref><ref id="ref103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>P</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Sullivan</surname><given-names>MA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice</article-title>. <source>Food Sci Nutr</source>. (<year>2023</year>) <volume>11</volume>:<fpage>7826</fpage>&#x02013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1002/fsn3.3700</pub-id>, PMID: <pub-id pub-id-type="pmid">38107095</pub-id>
</mixed-citation></ref><ref id="ref104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surampalli</surname><given-names>G</given-names></name><name><surname>Nanjwade</surname><given-names>BK</given-names></name><name><surname>Patil</surname><given-names>PA</given-names></name></person-group>. <article-title>Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery</article-title>. <source>Drug Deliv</source>. (<year>2016</year>) <volume>23</volume>:<fpage>512</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.3109/10717544.2014.923957</pub-id>, PMID: <pub-id pub-id-type="pmid">24937377</pub-id>
</mixed-citation></ref><ref id="ref105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Aquino</surname><given-names>E</given-names></name><name><surname>Muriel</surname><given-names>P</given-names></name></person-group>. <article-title>Beneficial effects of naringenin in liver diseases: molecular mechanisms</article-title>. <source>World J Gastroenterol</source>. (<year>2018</year>) <volume>24</volume>:<fpage>1679</fpage>&#x02013;<lpage>707</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v24.i16.1679</pub-id>, PMID: <pub-id pub-id-type="pmid">29713125</pub-id>
</mixed-citation></ref><ref id="ref106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arafah</surname><given-names>A</given-names></name><name><surname>Rehman</surname><given-names>MU</given-names></name><name><surname>Mir</surname><given-names>TM</given-names></name><name><surname>Wali</surname><given-names>AF</given-names></name><name><surname>Ali</surname><given-names>R</given-names></name><name><surname>Qamar</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Multi-therapeutic potential of naringenin (4&#x02032;,5,7-trihydroxyflavonone): experimental evidence and mechanisms</article-title>. <source>Plants</source>. (<year>2020</year>) <volume>9</volume>:<fpage>1784</fpage>. doi: <pub-id pub-id-type="doi">10.3390/plants9121784</pub-id>, PMID: <pub-id pub-id-type="pmid">33339267</pub-id>
</mixed-citation></ref><ref id="ref107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>R</given-names></name><name><surname>Kulkarni</surname><given-names>YA</given-names></name><name><surname>Wairkar</surname><given-names>S</given-names></name></person-group>. <article-title>Pharmacokinetic, pharmacodynamic and formulations aspects of naringenin: an update</article-title>. <source>Life Sci</source>. (<year>2018</year>) <volume>215</volume>:<fpage>43</fpage>&#x02013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2018.10.066</pub-id>, PMID: <pub-id pub-id-type="pmid">30391464</pub-id>
</mixed-citation></ref><ref id="ref108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>YN</given-names></name><name><surname>Zou</surname><given-names>YL</given-names></name><name><surname>Guo</surname><given-names>SD</given-names></name></person-group>. <article-title>Low-density lipoprotein particles in atherosclerosis</article-title>. <source>Front Physiol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>931931</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2022.931931</pub-id>, PMID: <pub-id pub-id-type="pmid">36111155</pub-id>
</mixed-citation></ref><ref id="ref109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younossi</surname><given-names>ZM</given-names></name><name><surname>Golabi</surname><given-names>P</given-names></name><name><surname>de Avila</surname><given-names>L</given-names></name><name><surname>Paik</surname><given-names>JM</given-names></name><name><surname>Srishord</surname><given-names>M</given-names></name><name><surname>Fukui</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis</article-title>. <source>J Hepatol</source>. (<year>2019</year>) <volume>71</volume>:<fpage>793</fpage>&#x02013;<lpage>801</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2019.06.021</pub-id><pub-id pub-id-type="pmid">31279902</pub-id>
</mixed-citation></ref><ref id="ref110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillman</surname><given-names>EJ</given-names></name><name><surname>Rolph</surname><given-names>T</given-names></name></person-group>. <article-title>FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases</article-title>. <source>Front Endocrinol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>601290</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2020.601290</pub-id>, PMID: <pub-id pub-id-type="pmid">33381084</pub-id>
</mixed-citation></ref><ref id="ref111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>PPAR-&#x003b3; signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets</article-title>. <source>Pharmacol Ther</source>. (<year>2023</year>) <volume>245</volume>:<fpage>108391</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pharmthera.2023.108391</pub-id>, PMID: <pub-id pub-id-type="pmid">36963510</pub-id>
</mixed-citation></ref><ref id="ref112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Ampelopsin improves insulin resistance by activating PPAR&#x003b3; and subsequently up-regulating FGF21-AMPK signaling pathway</article-title>. <source>PLoS One</source>. (<year>2016</year>) <volume>11</volume>:<fpage>e0159191</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0159191</pub-id>, PMID: <pub-id pub-id-type="pmid">27391974</pub-id>
</mixed-citation></ref><ref id="ref113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Lang</surname><given-names>L</given-names></name></person-group>. <article-title>Dihydromyricetin alleviates non-alcoholic fatty liver disease by modulating gut microbiota and inflammatory signaling pathways</article-title>. <source>J Microbiol Biotechnol</source>. (<year>2024</year>) <volume>34</volume>:<fpage>2637</fpage>&#x02013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.4014/jmb.2406.06048</pub-id><pub-id pub-id-type="pmid">39639497</pub-id>
</mixed-citation></ref><ref id="ref114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J-J</given-names></name><name><surname>Yao</surname><given-names>M-J</given-names></name><name><surname>Wu</surname><given-names>M-C</given-names></name></person-group>. <article-title>Study on biological efficacy of dihydromyricetin</article-title>. <source>Food Science</source>. (<year>2008</year>) <volume>29</volume>:<fpage>622</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="ref115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>P</given-names></name></person-group>. <article-title>A comprehensive review of vine tea: Origin, research on Materia Medica, phytochemistry and pharmacology</article-title>. <source>J Ethnopharmacol</source>. (<year>2023</year>) <volume>317</volume>:<fpage>116788</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jep.2023.116788</pub-id><pub-id pub-id-type="pmid">37343650</pub-id>
</mixed-citation></ref><ref id="ref116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>XA</given-names></name></person-group>. <article-title>Dihydromyricetin: a review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability</article-title>. <source>Trends Food Sci Technol</source>. (<year>2019</year>) <volume>91</volume>:<fpage>586</fpage>&#x02013;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tifs.2019.07.038</pub-id>, PMID: <pub-id pub-id-type="pmid">32288229</pub-id>
</mixed-citation></ref><ref id="ref117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Chaudhry</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Quercetin, inflammation and immunity</article-title>. <source>Nutrients</source>. (<year>2016</year>) <volume>8</volume>:<fpage>167</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu8030167</pub-id>, PMID: <pub-id pub-id-type="pmid">26999194</pub-id>
</mixed-citation></ref><ref id="ref118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Quercetin inhibits TNF-&#x003b1; induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway <italic>in vitro</italic></article-title>. <source>Medicine</source>. (<year>2020</year>) <volume>99</volume>:<fpage>e22241</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000022241</pub-id>, PMID: <pub-id pub-id-type="pmid">32957369</pub-id>
</mixed-citation></ref><ref id="ref119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>S</given-names></name><name><surname>Pevny</surname><given-names>S</given-names></name><name><surname>Ziegenhagen</surname><given-names>R</given-names></name><name><surname>Bakhiya</surname><given-names>N</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>B</given-names></name><name><surname>Hirsch-Ernst</surname><given-names>KI</given-names></name><etal/></person-group>. <article-title>Safety aspects of the use of quercetin as a dietary supplement</article-title>. <source>Mol Nutr Food Res</source>. (<year>2018</year>) <volume>62</volume>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.201700447</pub-id>, PMID: <pub-id pub-id-type="pmid">29127724</pub-id>
</mixed-citation></ref><ref id="ref120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Bo</surname><given-names>C</given-names></name><name><surname>Perna</surname><given-names>S</given-names></name><name><surname>Allehdan</surname><given-names>S</given-names></name><name><surname>Rafique</surname><given-names>A</given-names></name><name><surname>Saad</surname><given-names>S</given-names></name><name><surname>AlGhareeb</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Does the Mediterranean diet have any effect on lipid profile, central obesity and liver enzymes in non-alcoholic fatty liver disease (NAFLD) subjects? A systematic review and meta-analysis of randomized control trials</article-title>. <source>Nutrients</source>. (<year>2023</year>) <volume>15</volume>:<fpage>2250</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu15102250</pub-id><pub-id pub-id-type="pmid">37242133</pub-id>
</mixed-citation></ref><ref id="ref121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haigh</surname><given-names>L</given-names></name><name><surname>Kirk</surname><given-names>C</given-names></name><name><surname>El Gendy</surname><given-names>K</given-names></name><name><surname>Gallacher</surname><given-names>J</given-names></name><name><surname>Errington</surname><given-names>L</given-names></name><name><surname>Mathers</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis</article-title>. <source>Clin Nutr</source>. (<year>2022</year>) <volume>41</volume>:<fpage>1913</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2022.06.037</pub-id>, PMID: <pub-id pub-id-type="pmid">35947894</pub-id>
</mixed-citation></ref><ref id="ref122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirabelli</surname><given-names>M</given-names></name><name><surname>Chiefari</surname><given-names>E</given-names></name><name><surname>Arcidiacono</surname><given-names>B</given-names></name><name><surname>Corigliano</surname><given-names>DM</given-names></name><name><surname>Brunetti</surname><given-names>FS</given-names></name><name><surname>Maggisano</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>1066</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu12041066</pub-id>, PMID: <pub-id pub-id-type="pmid">32290535</pub-id>
</mixed-citation></ref><ref id="ref123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gantenbein</surname><given-names>KV</given-names></name><name><surname>Kanaka-Gantenbein</surname><given-names>C</given-names></name></person-group>. <article-title>Mediterranean diet as an antioxidant: the impact on metabolic health and overall wellbeing</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>. doi: <pub-id pub-id-type="doi">10.3390/nu13061951</pub-id>, PMID: <pub-id pub-id-type="pmid">34204057</pub-id>
</mixed-citation></ref><ref id="ref124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nani</surname><given-names>A</given-names></name><name><surname>Murtaza</surname><given-names>B</given-names></name><name><surname>Sayed Khan</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Hichami</surname><given-names>A</given-names></name></person-group>. <article-title>Antioxidant and anti-inflammatory potential of polyphenols contained in Mediterranean diet in obesity: molecular mechanisms</article-title>. <source>Molecules</source>. (<year>2021</year>) <volume>26</volume>. doi: <pub-id pub-id-type="doi">10.3390/molecules26040985</pub-id>, PMID: <pub-id pub-id-type="pmid">33673390</pub-id>
</mixed-citation></ref></ref-list></back></article>